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The professional and academic environment involved the OCD team at Haukeland 
University Hospital, which is formally part of The Bergen Group for Treatment 









In the spring of 2012 I moved to Bergen to start as a PhD student at the OCD 
team at Haukeland University Hospital (Helse Bergen). This marked the beginning of 
an incredible journey. 
During the preceding fall, in September 2011, Professor Gerd Kvale initiated to 
establish an OCD team in Helse Bergen. The Norwegian Health Authorities had 
decided that all health regions should establish OCD clinics during 2012, as a result of 
Associate Professor Bjarne Hansen’s tireless work. With the early establishment of the 
OCD team in Helse Bergen in 2011, the team made a head start, which was made 
possible thanks to the foresight by Director of Division of Psychiatry in Helse Bergen, 
Hans Olav Instefjord, who supported and facilitated the establishment of the team. 
Since this early beginning, the OCD team has expanded greatly. Our ambition 
has continuously been to further develop our services for those who need them the 
most. It is therefore gratifying to observe the emerging fruits of our labor. The present 
thesis describes the treatment and clinical effectiveness research conducted at the OCD 
team, and so far the work has been well-received. An especially gratifying recognition 
of our work was the recent award Innovation of the Year in Psychological Science, 
which was awarded to the team by The Norwegian Society for Psychological Science, 
for the development of the Concentrated Exposure Treatment (cET) format for OCD. 
I am proud to be part of the professional environment at the OCD team in Helse 
Bergen; an environment which may best be characterized by its creative atmosphere 
that allows for continuous innovation and expansion. At the foundation of the team’s 
work is the overreaching principle we constantly pursue:   
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Obsessive-compulsive disorder (OCD) is a debilitating disorder with a typically 
chronic course without treatment. The current thesis addresses the following research 
questions: The first aim is to provide an updated review of evidence-based 
psychological treatment for adult OCD. A traditional meta-analytic approach is 
combined with a systematic evaluation of the methodological quality of the included 
studies in order to provide recommendations for enhanced methodological stringency 
and study moderators of treatment outcome. These topics are addressed in Paper I. 
While randomized controlled trials (RCTs) can be considered the “gold standard” for 
treatment research, it can be argued that when evaluating a new treatment format, a 
pilot study followed by an effectiveness study and then a replication study is a 
preferable approach. The OCD-team in Helse Bergen, which is an out-patient clinic 
part of the specialist health care, has developed a novel treatment format of exposure 
based cognitive behavioral therapy where individually tailored and therapist assisted 
exposure and response prevention is delivered in a group format during four 
consecutive days. The second research aim was thus to assess to which extent OCD 
patients accepted the novel format, and to investigate its clinical effectiveness. 
Specifically changes in OCD symptoms, as well as changes in secondary outcomes 
like depression and work impairment, were investigated. These questions are 
addressed in a pilot study (Paper II) and an effectiveness study (Paper III). The third 
aim was to investigate if the results were replicable, which is addressed in Paper IV.  
Methods: Paper I includes all randomized controlled trials (RCTs) of cognitive 
behavioral treatment (CBT) for OCD. The term CBT was defined as treatment with 
CBT, cognitive therapy (CT) or exposure and response prevention (ERP). Included 
studies were published between 1993 and 2014 and used the interview-based Yale–
Brown Obsessive-compulsive Scale as a primary outcome measure. The paper 
provides a systematic review and meta-analysis of the included studies, as well as an 
evaluation of methodological aspects by using the Psychotherapy outcome study 




control, or waitlist conditions, and potential moderators were investigated with a 
subgroup analysis and meta-regression analyses.  
Paper II is a pilot study examining six patients undergoing Concentrated Exposure 
Treatment (cET), focusing on patients’ acceptance of treatment defined as proportion 
declining treatment, attrition and patients’ satisfaction; as well as clinical changes in 
OCD symptoms and depressive symptoms. OCD symptoms are assessed with the 
Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) and depressive symptoms with 
the Beck Depression Inventory (BDI). Acceptability is assessed with clinical 
interviews. 
Paper III is a larger effectiveness study that further investigates patients’ acceptance 
and the feasibility of cET. Treatment outcome on primary assessment of OCD 
symptoms is assessed with Y-BOCS and secondary assessment of depressive 
symptoms are assessed with BDI. Work impairment is assessed with clinical 
interview.  
Paper IV provides a replication study of Paper III with the aim to investigate whether a 
new patient sample undergoing cET would have comparable results as those obtained 
in Paper III when treatment is delivered by mainly other therapists than the developers 
of cET. Mixed models analyses and Chi square tests are applied to compare results on 
Y-BOCS, patient acceptance and occupational functioning.  
Results: In Paper I the overall effect sizes for comparisons with waiting list (1.31) and 
placebo conditions (1.33) were very large. Effect sizes for comparisons between 
individual and group treatment were small and non-significant. CBT was better than 
medication (0.55), and adding medication to CBT was not more effective than CBT 
with placebo (0.25). Of treatment moderators, proportion of women, higher age and 
concurrent SSRI medication were associated with lower effect sizes. Moderators 
related to larger effect sizes were higher initial symptom severity, using completer 




opposed to active control conditions, and studies assessing therapist competence. 
Overall mean methodological score was 23.03 (SD 4.37) in the 37 studies. 
The results from Paper II indicated high patient acceptance: None of the patients 
declined participation, no patients dropped out and the patients expressed a high 
degree of treatment satisfaction. All patients had marked reductions in symptoms of 
OCD and depression. Follow-up assessments revealed that the treatment results to a 
large extent were maintained three and six months after treatment. 
In Paper III there was high treatment acceptability. Two patients (5.4%) declined the 
offer of treatment and one patient (3%) dropped out prematurely. Ninety percent of the 
patients reported a high degree of treatment satisfaction, indicating that cET is an 
acceptable format. The sample had significant reductions in obsessive-compulsive 
symptoms after treatment, with gains maintained at the three- and six-month follow-
ups. By analyzing clinically significant changes, 77% of the patients were classified as 
recovered six months after treatment, which is promising as the majority had long 
OCD duration and most patients had unsuccessfully tried previous treatment. 
The results in Paper IV showed that the patients had high treatment acceptance, as 
indicated by no patients declining treatment, no treatment dropout and high self-
reported treatment satisfaction. Most patients had marked and significant reductions in 
symptoms of OCD, with long-term gains maintained at three and six months. By 
comparing the results with those obtained in Paper III, the most important finding was 
that equal treatment outcome was achieved by different therapists in a new sample of 
patients.  
Conclusions: The present thesis shows that CBT is an effective treatment for OCD, 
however, the methodological quality of the RCTs is characterized by several 
limitations with considerable room for improvement. Suggestions of enhanced 
methodological stringency in future efficacy studies are offered. Furthermore, the 
thesis shows that a concentrated four-day treatment format is well accepted by the 




obtained in terms of the replicability of the format, and it was concluded that Paper IV 
offered a successful replication of Paper III, also when treatment was delivered by 
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1.1 What is OCD? 
Obsessive-compulsive disorder (OCD), as defined in the Diagnostic and 
Statistical Manual of Mental Disorders 4th edition (DSM-IV;  American Psychiatric 
Association, 1994), is characterized by recurrent obsessions or compulsions that are 
time consuming and cause marked distress or impairment (Table 1)1. Obsessions are 
recurrent and persistent thoughts, urges, or images that are experienced as intrusive 
and unwanted. The affected individual tries to ignore or suppress these thoughts, urges 
or images, or tries to neutralize them by performing a compulsion. Typical obsessions 
are fear of contamination, thoughts about excessive responsibility (like fear of causing 
fire), or inappropriate thoughts with sexual or aggressive content. Obsessions are 
experienced as ego-dystonic, which means that they are inconsistent with the person’s 
beliefs, attitudes and desires. Compulsions are physical or mental actions that are 
performed in response to obsessions in order to prevent a feared catastrophic outcome 
or to reduce anxiety and discomfort. In order to be diagnosed with OCD, the patient 
must, at some point, experience the obsessions as excessive or unwanted. OCD causes 
significant functional impairment, as well as difficulties with social and family 
functioning. Without treatment, the disorder typically has a chronic course (American 
Psychiatric Association, 1994). The World Health Organization has ranked OCD as 
one of the ten most debilitating disorders in terms of lost income and impaired quality 
of life (Murray & Lopez, 1996).   
 
 
                                              
1 In the present thesis, the DSM-IV criteria for OCD are applied, as the DSM-5 (American Psychiatric Association, 2013) 




Table 1. Diagnostic criteria for obsessive-compulsive disorder (American Psychiatric 
Association, 1994) 
A. Either obsessions or compulsions:  
Obsessions as defined by (1), (2), (3), and (4):  
(1) recurrent and persistent thoughts, impulses, or images that are 
experienced, at some time during the disturbance, as intrusive and 
inappropriate and that cause marked anxiety or distress 
(2)  the thoughts, impulses, or images are not simply excessive worries 
about real-life problems  
(3) the person attempts to ignore or suppress such thoughts, impulses, or 
images, or to neutralize them with some other thought or action  
(4) the person recognizes that the obsessional thoughts, impulses, or 
images are a product of his or her own mind (not imposed from 
without as in thought insertion)  
Compulsions as defined by (1) and (2):  
(1) repetitive behaviors (e.g., hand washing, ordering, checking) or mental 
acts (e.g., praying, counting, repeating words silently) that the person 
feels driven to perform in response to an obsession, or according to 
rules that must be applied rigidly  
(2) the behaviors or mental acts are aimed at preventing or reducing 
distress or preventing some dreaded event or situation; however, these 
behaviors or mental acts either are not connected in a realistic way 





A. At some point during the course of the disorder, the person has recognized 
that the obsessions or compulsions are excessive or unreasonable. Note: This 
does not apply to children.  
B. The obsessions or compulsions cause marked distress, are time consuming 
(take more than 1 hour a day), or significantly interfere with the person’s 
normal routine, occupational (or academic) functioning, or usual social 
activities or relationships.  
C. If another Axis I disorder is present, the content of the obsessions or 
compulsions is not restricted to it (e.g., preoccupation with food in the 
presence of an Eating Disorders; hair pulling in the presence 
of Trichotillomania; concern with appearance in the presence of Body 
Dysmorphic Disorder; preoccupation with drugs in the presence of 
a Substance Use Disorder; preoccupation with having a serious illness in the 
presence of Hypochondriasis; preoccupation with sexual urges or fantasies in 
the presence of a Paraphilia; or guilty ruminations in the presence of Major 
Depressive Disorder).  
E. The disturbance is not due to the direct physiological effects of a substance 
(e.g., a drug of abuse, a medication) or a general medical condition.  
 
1.2 Prevalence  
 OCD was once believed to be a rare condition, with early estimates 
reporting that only 0.05% of the population was affected (Woodruff & Pitts, 1964). 
Although it is now recognized that OCD is more common than noted in these early 
reports, the prevalence estimates varies considerably between studies. One proposed 




sufficiently skilled to, on the one hand, recognize OCD, and, on the other, differentiate 
OCD from other anxiety disorders, for example, differentiating obsessions from worry 
or rumination (Stein, Forde, Anderson, & Walker, 1997). Estimates based on clinically 
recognized OCD indicate a prevalence rate of less than 1% (Fireman, Koran, 
Leventhal, & Jacobson, 2001), whereas a Norwegian study applying DSM-III-R 
criteria for OCD reported a lifetime prevalence of 1.6% in the capital city, with a 
lower rate of 0.6% in rural areas, following the administration of diagnostic interviews 
using 1,080 subjects drawn from a random sample of 107,738 Norwegian residents 
(Kringlen, Torgersen, & Cramer, 2006). A higher prevalence rate was reported in an 
early epidemiological study, which found a 12-month prevalence of 1–2% and a 
lifetime prevalence of 2–3% (Karno, Golding, Sorenson, & Burnam, 1988), which 
were very similar to recent prevalence rates estimated by the National Institute of 
Mental Health (NIMH). Based on a nationally representative survey of U.S. adults, a 
lifetime prevalence rate of 2.3% and a 12-month prevalence rate of 1.2% were 
reported using clinician-administered interviews (Kessler, Berglund, et al., 2005; 
Kessler, Chiu, Demler, & Walters, 2005; Ruscio, Stein, Chiu, & Kessler, 2010). In 
summary, recent studies seem to indicate that OCD is more prevalent than previously 
believed and a more correct estimate of prevalence may be that 1% of the population 
has OCD at any point in time, with a lifetime prevalence of about 2%.  
1.3 Onset  
 The typical age of onset for OCD is somewhat unclear as studies of the 
pediatric and the adult patient populations have reported different findings. Whereas 
studies of children with OCD report a peak age of onset of about ten years (Flament et 
al., 1988; Geller, Biederman, Jones, Shapiro, et al., 1998), adult studies show that only 
between 30–50% of adults with OCD report that the disorder developed in childhood 
(Pauls, Alsobrook, Goodman, Rasmussen, & Leckman, 1995; Rasmussen & Eisen, 
1990). These results may suggest that for some pediatric patients, obsessive-




onset of 20–21 years was reported and based on this observation, it was suggested that 
early and late age of onset be distinguished as distinct subtypes of OCD (Anholt et al., 
2014; Karno et al., 1988).  
OCD appears to affect both female and male patients with equal frequency in 
adult samples (Karno et al., 1988). For juvenile samples of OCD patients, a higher 
prevalence in males has been reported (Geller, Biederman, Jones, Park, et al., 1998; 
Hanna, 1995). In addition, there are data to suggest gender related clinical differences 
in children with OCD, with studies showing more incidences of early-onset in males 
(Mathis et al., 2011; Ruscio et al., 2010). It has been suggested that early-onset may be 
a distinct subtype of OCD characterized by higher symptom severity and higher 
prevalence of OCD in family members, as well as a higher prevalence of comorbid 
OCD-spectrum disorders, although not necessarily related to treatment outcome 
(Taylor, 2011). A recent study (Torp et al., 2015) investigating 20 potential treatment 
predictors in a large sample of 269 pediatric participants in The Nordic Long-term 
OCD Treatment Study (NordLOTS; Thomsen et al., 2013), found only age to be a 
predictor of treatment outcome, with younger children improving more compared to 
older children. Symptoms of OCD typically increase and decrease over time, often in 
response to stress (Mataix-Cols, Marks, Greist, Kobak, & Baer, 2002). Without 
treatment, OCD appears chronic, at least in the short term. However, some reports also 
indicate that in the longer term OCD may have a fluctuation course, with remission or 
at least symptom reduction over time (Marcks, Weisberg, Dyck, & Keller, 2011; 
Skoog & Skoog, 1999).  
 There is no consensus regarding subtypes of OCD, but based on factor 
analytical procedures to the content of typical obsessions, four subtypes have been 
suggested: “Contamination”, “responsibility”, “unacceptable thoughts” and 
“symmetry”. The typical compulsions for these obsessions are washing, checking, 
neutralizing thoughts and ordering (Abramowitz et al., 2010). In the DSM-IV, 
hoarding was listed as a criterion for OCD, but this classification was controversial, 




subtypes of OCD (Mataix-Cols et al., 2010). As a consequence, hoarding disorder was 
established as a separate disorder in the DSM-5, and included in a new category called 
obsessive-compulsive and related disorders (American Psychiatric Association, 2013).  
The experience of thoughts with comparable content as typical obsessions is a 
rather normal phenomenon in the general population. A study showed that 90% of 
responders reported intrusive thoughts with close resemblance to the those reported by 
obsessional patients (Rachman & de Silva, 1978). Salkovskis and Harrison (1984) 
later carried out a replication study with comparable results. 
1.4 Comorbidity 
Comorbid conditions are frequently reported in patients with OCD, and Ruscio 
et al. (2010), using data from 2073 respondents diagnosed with lifetime OCD from the 
National Comorbidity Survey Replication, reported a comorbidity rate of 90%. The 
most common comorbid psychiatric conditions were anxiety disorders (75.8%) and 
mood disorders (63.3%). Clinical studies have reported that 50% had at least one 
additional comorbid disorder (Eddy, Dutra, Bradley, & Westen, 2004). Studies have 
also been conducted to investigate the incidence of comorbid Axis II disorders in 
patients with OCD; nevertheless, due to the large variability in the reported 
prevalence, the exact Axis II comorbidity rate is unclear. Crino and Andrews (1996b) 
assessed 258 patients with anxiety disorder, 80 of whom were diagnosed with OCD, 
and by applying the clinician administered Personality Disorder Examination 
(Loranger, 1988), the prevalence rate for personality disorders was found to be 9%. 
However, this is a much lower incidence rate than that reported in other studies. 
Vogel, Stiles, and Götestam (2004) reported that 66% of a sample 35 treatment 
seeking OCD patients had at least one comorbid personality disorder, according to the 
administration of the Structured Clinical Interview for DSM-III-R Personality 
Disorders (SCID-II; Spitzer, Williams, Gibbon, & First, 1990). Black, Noyes, Pfohl, 




prevalence rate of 87% Axis II disorders in a sample of 32 OCD patients. Despite 
these differences in reported prevalence rates of comorbid disorders in samples of 
OCD patients, it appears safe to conclude that a majority of patients with OCD 
experience comorbid conditions and that comorbidity in general seems to be the rule 
rather than the exception. Moreover, comorbidity appears to be a major factor in 
poorer quality of life in OCD patients, as this has been found to be largely influenced 
by comorbid depression (Huppert, Simpson, Nissenson, Liebowitz, & Foa, 2009). 
With the additional findings that OCD patients in general have impaired occupational 
functioning (Mancebo et al., 2008) it is clear that untreated, this group of patients 
experience a high degree of suffering.  
1.5 A Brief Overview of Treatment for OCD  
1.5.1 The emergence of Exposure and response prevention 
 Until the mid-1960s, OCD was considered a treatment-resistant disorder 
(Franklin & Foa, 2007). Prior to this, the main therapeutic effort was psychodynamic 
therapy, although this approach was not empirically supported (Abramowitz, 2006). 
The 1950s and 1960s marked progress in the field of treatment of anxiety in general 
with the development of behavior therapy. For example, Wolpe (1968) developed 
systematic desensitization, which proved effective for patients with anxiety, especially 
for the (then-called) simple phobias. The treatment approach involved a stepwise and 
systematic confrontation with fear-inducing stimuli following a pre-defined hierarchy 
and conducted while the patient was in a relaxed state. Although the method 
represented major progress in the treatment of anxiety, patients with OCD did not 
improve using this approach (Foa, 2010).  
 Meyer (1966) was the first to describe successful treatment of OCD. Meyer 
developed the treatment method later named exposure and response prevention (ERP). 
In what can be termed as a pilot case study, he demonstrated how patients who had not 




confronting anxiety provoking situations without engaging in anxiety reducing 
behavior. The treatment was conducted while patients were hospitalized and involved 
daily two-hour exposure sessions while patients were simultaneously encouraged not 
to engage in ritualistic behavior. In the initial description of the treatment, Meyer 
(1966) presented two cases of patients who were hospitalized for 12 weeks and nine 
weeks, respectively. One patient had a fear of contamination and excessive hand 
washing as primary OCD symptoms and during treatment, the patient was exposed to 
various objects and situations. In order to prevent compulsions from being performed, 
Meyer (1966) described that “Persuasion, reassurance and encouragement were used” 
(p. 277); in addition, water taps in the patient’s room were turned off. The paper also 
describes that after the residential treatment, patients were given outpatient follow-up 
sessions lasting over one year for the first patient and almost two years for the second. 
In a later effectiveness study, Meyer et al. (1974) found that of 15 patients receiving 
treatment, ten had significant improvement that was maintained five years after 
treatment for the majority of patients, pointing to promising long term treatment gains 
using ERP. Although Meyer first demonstrated the effectiveness of ERP in a 
residential unit, he also later showed that the treatment could be successfully 
conducted in the patient’s home environment (Meyer, Robertson, & Tatlow, 1975), 
which was an early demonstration of the potential for dissemination inherent in the 
treatment principles.  
 Interestingly, Meyer et al. (1974) results showing two thirds of patients 
improving considerably, are basically comparable to the reported treatment outcome 
across many later treatment studies of ERP. In addition, Fisher and Wells (2005) 
review showed that statistically reliable improvement was obtained by 75% of patients 
treated with ERP. Obviously, this also opens the doors for a gloomier interpretation, as 
these findings imply that treatment of OCD has not improved much since ERP was 
first developed. It may also be remarked that Meyer’s initial pilot study (Meyer, 1966) 
and the later effectiveness study (Meyer et al., 1974) represent a stepwise research 




descriptions both of the treatment content and the patients’ response to the treatment. 
A larger effectiveness trial followed this. When these two initial studies were shown to 
have an effect, this laid the foundation for later randomized controlled studies.  
In the 1970s, ERP was further evaluated and included in controlled studies (e.g. 
Boersma, Den Hengst, Dekker, & Emmelkamp, 1976; Emmelkamp & Kraanen, 1977; 
Foa & Goldstein, 1978). By the end of the decade, the evidence base strongly favored 
ERP as an effective treatment for OCD. Dismantling research was conducted in an 
attempt to identify which components of the treatment were responsible for the 
treatment effect. For example Foa and colleagues (Foa, Steketee, Grayson, Turner, & 
Latimer, 1984; Foa, Steketee, & Milby, 1980) examined separately the effect of 
exposure alone, response prevention alone, and the combination, with combined 
treatment showing superior effects over each of the individual components alone.  
Later studies demonstrated that ERP was transportable to clinical outpatient 
settings as a treatment format with 15 daily two-hour sessions delivered over three 
weeks (Foa et al., 1984; Foa et al., 1980). The optimal frequency of sessions was also 
investigated and Emmelkamp, van den Heuvell, Rüphan, and Sanderman (1989) found 
no difference between short and long intervals between treatment sessions. In a later 
study, Abramowitz, Foa, and Franklin (2003) compared intensive ERP and twice-
weekly ERP. The results showed that a protocol of eight weeks duration with twice-
weekly sessions was as effective as intensive treatment with daily sessions for three 
weeks. These outpatient treatment studies were important as they demonstrated that 
ERP could be disseminated from the initial inpatient treatment studies to regular 
outpatient clinics. 
1.5.2 Cognitive behavioral therapy 
 Despite initial optimism due to the promising treatment effects of ERP, in the 
years following it was consistently established that a substantial proportion of patients 
receiving the treatment do not improve (Fisher & Wells, 2005). After cognitive 




and CT were combined in the treatment of OCD in order to investigate if treatment 
effects were enhanced. The combination of CT and ERP has typically been termed 
cognitive behavioral therapy (CBT).  
 A relevant question is if and to what extent combined therapy gives enhanced 
effect compared to the individual treatment alone. With respect to answering whether 
treatment is improved by combining the two treatment approaches, the empirical 
findings are mixed (Abramowitz, Taylor, & McKay, 2005). For instance, in a group 
treatment study of OCD where McLean et al. (2001) compared ERP and CBT, the 
results showed that at post-treatment and at the three-month follow-up, the ERP 
condition was associated with marginally higher levels of symptom reduction, whereas 
for a clinically significant change, more patients in the ERP condition were recovered 
at the three-month follow-up.  
Yet other studies have demonstrated equal results of ERP and CBT. Vogel et al. 
(2004) study compared the combination of ERP and CT to ERP and a psychological 
placebo, finding that adding cognitive therapy to ERP did not improve the ERP 
treatment, although patients who received additional cognitive therapy were 
significantly less likely to drop out. Whittal, Thordarson, and McLean (2005) 
randomized patients to 12 weeks of CBT or 12 weeks of ERP and the results showed 
that the groups did not differ significantly in terms of clinically significant change, 
although there were somewhat more recovered patients in the CBT condition, relative 
to the patients receiving ERP.  
1.6 Treatment Formats of OCD 
Since Meyer (1966) first demonstrated that OCD can be treated with ERP, there 
has been an interesting development in the way treatment is delivered. The initial 
treatment results were based on inpatient treatment, whereas outpatient treatment now 
is most commonly delivered (NICE, 2006).  CBT/ERP has been demonstrated as a 




categorized according to a diversity of characteristics, e.g. whether the treatment is 
delivered individually, in a group or family; yet other characteristics may be related to 
treatment duration, frequency of sessions and number of sessions. Below is a brief 
presentation of some different treatment formats of OCD.  
1.6.1 Individual treatment  
While CBT has been delivered in different formats, individual treatment is the 
most common format of treatment delivery, for example Rosa-Alcázar, Sánchez-Meca, 
Gómez-Conesa, and Marín-Martínez (2008) found 14 study comparisons with 
individual treatment compared to six study comparisons with group CBT. Studies have 
investigated different frequencies of treatment delivery, for example daily sessions 
over three weeks (Franklin, Abramowitz, Kozak, Levitt, & Foa, 2000) and twice-
weekly sessions over eight weeks (Abramowitz et al., 2003). Duration of sessions also 
vary between studies, with some studies applying sessions of 45 minutes (e.g. van 
Balkom et al., 1998), while others have applied longer sessions lasting two hours (e.g. 
Vogel et al., 2004). In the NICE (2006) clinical guideline it is recommended that 
patients with OCD initially are offered brief treatment courses of up to 10 hours, 
which may be extended if treatment response is not seen after 10 hours. It is however a 
challenge to summarize the different approaches as there is a striking lack of 
replications of the different variations. Many studies have investigated different 
variants of ERP, varying both in terms of duration, frequency and length of sessions. 
Although the guidelines have direct suggestions for number of hours needed in the 
treatment of OCD, it is unclear how much therapy is sufficient. For example as 
indicated by Rosa-Alcázar et al. (2008) who found that treatment duration in weeks, 
number of hours per week and total number of hours were unrelated to treatment 
outcome. However, a methodological aspect which was not addressed by Rosa-
Alcázar et al. (2008) is if the amount of therapy hours differed between treatment and 




1.6.2 Group treatment 
Group treatment for OCD is suggested as a cost-effective approach to the 
treatment of OCD. Jónsson and Hougaard (2009) systematically reviewed and meta-
analyzed 13 group treatment studies for OCD. Effect sizes from group therapy and 
individual therapy did not differ significantly, but the meta-analysis included only one 
study that directly compared group to individual treatment formats. The authors, 
therefore, cautioned that there was insufficient data to draw conclusions on the relative 
effectiveness of group treatment and individual treatment. A literature search reveals 
that there are at least five RCTs using clinician administered Y-BOCS to compare 
individual and group treatment, of which only one (Anderson & Rees, 2007) was 
included in Jónsson and Hougaard (2009) meta-analysis. Thus, the relative effect of 
group and individual therapy should be investigated in future studies and meta-
analyses.  
1.6.3  Family treatment 
 Given that family members often become involved in a patient’s ritualistic 
behavior (Lebowitz, Panza, Su, & Bloch, 2012), family based treatments have been 
developed that specifically aim at targeting dysfunctional family accommodations. 
Emmelkamp, de Haan, and Hoogduin (1990) study showed equal results between 
conditions with and without family involvement. This study was conducted one year 
after the Y-BOCS was published and therefore did not use this measure that later 
became the “gold standard” for assessment of OCD symptoms (Frost, Steketee, 
Krause, & Trepanier, 1995). This makes it difficult to compare this study to later 
studies in terms of treatment outcome. Franklin and Foa (2007) summarized the results 
as only presenting modest symptom reduction, suggesting that the lack of therapist-
assisted exposure and only twice-weekly home assignments of self-exposure might 




 Grunes, Neziroglu, and McKay (2001) described a family treatment approach 
with an eight-week family intervention group and compared results with patients who 
received individual treatment. The results showed that the family intervention group 
had a 26% symptom reduction, which was larger than were the results of the 
individual treatment group. It should be noted that the patients treated individually had 
only a 9% reduction in Y-BOCS assessed symptom severity. This is markedly lower 
than was the percentage of symptom reduction typically reported in individual 
treatment studies (Farris, McLean, Van Meter, Simpson, & Foa, 2013; Franklin et al., 
2000). Also, at follow-up, the family group had a mean Y-BOCS score greater than 19, 
which is higher than the >16 Y-BOCS score often used as inclusion criteria in 
treatment studies (Farris et al., 2013). 
  In a recent meta-analysis of 29 studies of family involvement in the treatment 
of OCD, it was found that “family-inclusive treatment” yielded an overall large effect 
size of 1.68 (Thompson-Hollands, Edson, Tompson, & Comer, 2014). However, only 
nine of the studies were randomized controlled trials, and of these, four had waitlist or 
placebo as the control condition. With only five RCTs, the relative effect of family 
involvement compared to other treatment variants is yet to be established. Thus more 
well-controlled studies on the potential augmenting effect of adding family 
involvement in the treatment of OCD are warranted.  
1.6.4  Remote  treatment  
Recently, there have been advances in the application of electronic solutions in 
the remote treatment of OCD. Among several remote modes of treatment, Internet and 
teleconference treatment approaches have been developed. Several studies have 
evaluated Internet delivered treatment (Andersson et al., 2012; Wootton, Dear, 
Johnston, Terides, & Titov, 2013). Wootton et al. (2013) randomized 56 patients to 
bibliotherapy, Internet CBT or waiting list groups. There were no significant 
differences between the bibliotherapy group and the Internet CBT group. That the 




finding. Also, studies using teleconference-based treatment have showed promising 
results. In a pilot study, Vogel et al. (2014) randomized patients to videoconference 
treatment, bibliotherapy and waiting list, and found that six of ten patients receiving 
treatment via videoconference were classified as recovered, using the Jacobson and 
Truax (1991) criteria for clinically significant change. It is worth noting that the 
patients in the bibliotherapy group, who were provided with a self-help book, had no 
treatment gains, in contrast with Wootton et al. (2013) treatment outcomes. 
Wootton (in press) recently reviewed the literature on various remote 
treatments. The meta-analysis showed that remote treatment is associated with large 
effect sizes. However, there were several methodological limitations in the included 
studies and consequently the conclusions must be considered preliminary. Some 
studies did not conduct an assessment of diagnosis using structured interviews, which 
threatens the reliability of the OCD diagnosis. Both randomized and uncontrolled 
studies were analyzed together, and of the controlled studies waitlist controls were 
frequently applied, which is unfortunate given that uncontrolled studies may yield 
larger effect sizes than controlled studies, and wait-list control may give larger effect 
sizes than active control comparison. In addition both pediatric and adult samples were 
analyzed together. The empirical status for remote treatment is thus still unclear. 
1.6.5 Inpatient treatment 
The NICE (2006) guidelines suggested inpatient treatment with specific OCD 
expertise as the highest level of care that should be offered to a small proportion of 
patients who have not responded to previous pharmacological or psychological 
treatment trials over long periods of time. An important issue, thus, is the evidence 
base for inpatient treatment as an option for treatment refractory patients.  
A recent meta-analysis investigated the empirical status of inpatient, day 
patient and residential unit OCD treatment for adults (Veale et al., 2016). Nineteen 




of stay was 10.4 weeks, ranging from five weeks to 19.3 weeks. Between admission 
and discharge, the mean decrease in Y-BOCS score was 10.7 points, which equaled an 
overall effect size of 1.87. Length of stay was unrelated to treatment outcome.  
Unfortunately, the studies reviewed by Veale et al. (2016) were characterized 
by methodological limitations. For example, not all studies conducted an assessment 
of diagnosis with structured clinical interviews, assessment of the adequacy of 
previous pharmacological and psychological treatment trials was not systematically 
reported, and few studies included follow-up assessment in order to evaluate the long 
term treatment outcome after the patients were discharged. Due to these 
methodological considerations of the studies analyzed by Veale et al. (2016) there is  
need for more research with increased methodological quality on inpatient treatment in 
order to establish if this is the right level of treatment for patients with high symptom 
severity and previous unsuccessful treatment attempts.  
1.6.6 Summary  
A range of different formats has been evaluated in the treatment of OCD. Even 
though a substantial number of controlled studies have been conducted, the lack of 
replication studies is maybe one of the most striking aspects of the treatment literature. 
Replication studies are a fundamental component for science to progress (Jasny, Chin, 
Chong, & Vignieri, 2011), still, replication studies are rarely conducted in the clinical 
psychological literature (Makel, Plucker, & Hegarty, 2012). Moreover, a recent study 
showed that of 100 psychology studies that were aimed to be replicated, only 36% of 
the original findings were replicated with statistically significant results. And in those 
cases where the original results were replicated, the replication studies had lower 
effect sizes than the original study (Open Science Collaboration, 2015). That 
replication studies are conducted so rarely is surprising, given that an important reason 




1.7 Meta-analyses on Treatment of OCD – Why the Need for Another? 
CBT has extensive empirical support in the treatment of OCD, as evident from 
a number of systematic reviews and meta-analyses investigating both efficacy and 
effectiveness (Abramowitz, 1996, 1997, 1998; Abramowitz, Franklin, & Foa, 2002; 
Eddy et al., 2004; Kobak, Greist, Jefferson, Katzelnick, & Henk, 1998; Olatunji, 
Davis, Powers, & Smits, 2013; Rosa-Alcázar et al., 2008; van Balkom et al., 1994).  
Despite the relatively large number of previous meta-analyses on treatment of 
OCD it can be argued that there are several reasons that warrant an updated meta-
analysis. Firstly, the most recent meta-analysis on CBT for OCD was conducted by 
Olatunji et al. (2013). As the main aim of that meta-analysis was to examine the 
efficacy of CBT in studies comparing CBT to placebo or passive control conditions, 
only 16 studies published between 1993 and 2010 were included; of these, three were 
pediatric studies and 13 were adult studies. Due to the strict inclusion and exclusion 
criteria, 21 relevant studies comparing active treatments were excluded. This meta-
analysis is thus characterized by a low number of adult treatment studies analyzed.  
Secondly; prior to Olatunji et al. (2013), Rosa-Alcázar et al. (2008) conducted a 
meta-analysis of psychological treatment of OCD. Since this meta-analysis more than 
20 RCTs have been published. Thus, a large number of treatment studies have yet to 
be meta-analytically reviewed, which warrants an updated meta-analysis on the 
treatment literature.  
A third reason for an updated meta-analysis is related to methodological issues. 
As mentioned previously, many treatment studies of OCD are characterized by 
limitations with respect to the methodological quality. This issue should be 
investigated systematically, which has not been performed in previous meta-analyses 
(see Table 2 and below).    
Fourthly; of the previous meta-analyses published, the outcome measured in the 




many different outcome measures for OCD have been developed. Since it was 
presented, the Y-BOCS has reached wide application and an extensive number of 
studies have used this scale to assess OCD severity. A meta-analysis including only 
studies using this scale will have advantages, like avoiding having to standardize 
scores across different measures, which may bias the results. A related issue concerns 
assessment of treatment response. Many previous meta-analyses only calculated effect 
sizes as the overall measure of treatment outcome and only two studies reported 
proportion of remitted patients (see Table 2). Effect sizes can be criticized for not 
reflecting clinically significant change, as opposed to e.g. the criteria proposed by 
Jacobson and Truax (1991). An updated meta-analysis in which response rates are 
calculated based on one outcome scale should thus be preferred. 
A fifth argument in favor of an updated meta-analysis on OCD concerns the 
notion that CBT is a challenging treatment. This has been suggested to explain an 
often-cited attrition and refusal rate of 25-30 % (Franklin & Foa, 1998). These rates 
should be critically analyzed across studies in order to establish if they are generally 
representable for CBT of OCD. Lastly, as mentioned briefly above, treatment of OCD 
has been developed across multiple formats. To what extent the mode of treatment is 
related to treatment outcome should be analyzed meta-analytically, given the large 
number of studies published since the last updated meta-analysis of OCD.  
1.8 Recent Meta-analyses on OCD 
The two most recent meta-analyses on psychological treatment of OCD were 
conducted by Olatunji et al. (2013) and Rosa-Alcázar et al. (2008). Of the 16 included 
studies in Olatunji et al. (2013), five studies were published after the meta-analysis by 
Rosa-Alcázar et al. (2008). The inclusion of only studies with passive control 
conditions in Olatunji et al. (2013) should be noted, as it is well established that OCD 
has a chronic course over the short term (Marcks et al., 2011), consequently, patients 
in passive control conditions are not expected to improve as there is no evidence to 




CBT and waitlist controls will thus be expected to yield large and significant 
differences between the groups in favor of the active condition. Comparisons with 
waiting list controls and placebos may yield inflated effect sizes, evident form research 
consistently showing larger effect sizes for comparisons between treatment and 
passive control compared to studies showing differences between treatment and active 
control conditions (Baskin, Tierney, Minami, & Wampold, 2003; Furukawa et al., 
2014; Sundell & Ferrer-Wreder, 2014). To avoid biased large effect sizes, active 
control conditions should be preferred.  
A finding worth noting in Olatunji et al. (2013) is that five of the six studies that 
utilized placebos used psychological placebos (e.g. anxiety management or relaxation) 
and the results showed that effect size for CBT vs. placebo was smaller compared to 
CBT vs. waiting list. However, although psychological placebo is not an effective 
treatment for OCD, there was some change in patients in this group, implying that any 
therapist’s attention may lead to some limited symptom reduction. Also, it is possible 
that psychological placebos (e.g. anxiety management) may incorporate some 
psychoeducation, which may encourage the patient to confront anxiety-evoking 
situations and reduce safety behaviors. Thus, the contents of psychological placebos 
should be controlled in treatment studies and be evaluated in meta-analytic reviews in 
order to avoid potential confounding therapy elements in the control condition. 
Rosa-Alcázar et al. (2008) included studies with placebos or waiting list 
controls, in addition to studies with active control conditions. The inclusion of 19 adult 
studies published between 1980 and 2006 makes this the most recent and largest meta-
analysis up until now of the adult treatment literature on OCD. The inclusion period 
ended in 2006, which means that studies published within the last nine years of the 
present date have yet to be reviewed using meta-analytic procedures. There is, 
therefore, a need for an updated meta-analysis covering the time period following the 




Previous meta-analyses have aimed at investigating if ERP can be augmented 
by adding cognitive therapy. Rosa-Alcázar et al. (2008) meta-analysis reported very 
similar effect sizes of ERP alone (d = 1.127), CT alone (d = 1.090) and ERP with CT 
(d = 0.998). Cohen (1992) has defined effect sizes of 0.20–0.49 as small, 0.50–0.79 as 
medium, and > 0.80 as large, and accordingly, all the reported effect sizes were very 
large. Although these reported effects are not statistically different, it is an interesting 
finding that the mean effect of the combined ERP and CT treatment was somewhat 
lower compared to ERP and CT alone. The authors urge caution when interpreting 
these results due to variation in the number of studies in each type of treatment (13 
groups with ERP, eight groups combining ERP and CT and only three groups of CT 
alone); however, if treatment is not enhanced by adding additional therapy elements to 
ERP, this means that there is no need for including additional cognitive interventions. 
Still, the large proportions of treatment participants who do not improve from ERP 
represent an important group of patients for which it is of uttermost importance to 
develop improved treatment strategies. This area should be further investigated both in 
treatment studies and using meta-analytic procedures. 
 Comorbidity is common in OCD patients. To what extent, if any, comorbid 
conditions influence the outcome of treatment for OCD has been meta-analytically 
investigated. Olatunji et al. (2013) analyzed moderators of treatment outcome for OCD 
and found no significant relationship between percentage of comorbid disorders and 
effect size. Pre-treatment levels of depression were also unrelated to treatment 
outcome. The authors concluded that the results were consistent with a previous meta-
analysis that found that overall comorbidity did not influence the treatment outcome of 
CBT for anxiety disorders. Olatunji et al. (2013) analysis is limited due to the low 
number of included studies, as only 16 efficacy trials were analyzed, and three of these 
were pediatric studies. The authors, therefore, stated that more research on predictors 
of treatment outcome are needed. The findings from this meta-analysis contradicted 
Rosa-Alcázar et al. (2008) previous and larger meta-analysis using dichotomous 




comorbidity as a treatment predictor. The initial results showed a significantly higher 
effect size for studies with high comorbidity. However, when the study with the 
highest attrition rate (Vogel et al., 2004) was removed from the analysis, as the authors 
suggested that patients with high comorbidity may be more likely to drop out of 
treatment prematurely, the difference was no longer statistically significant. In 
summary, although one may suspect that OCD patients with comorbidity would profit 
less from CBT, this hypothesis is not supported by the results from the most updated 
meta-analyses. In the treatment of anxiety disorders (panic disorder, agoraphobia and 
PTSD), a positive effect of comorbidity on treatment outcome was found (Olatunji, 
Cisler, & Tolin, 2010). This issue should receive more empirical investigation, as 
concluded in Olatunji et al. (2013) recent meta-analysis.  
1.9 Methodological Quality in Previous Meta-analyses 
Even though there have been numerous evaluations of treatment efficacy and 
the effectiveness of OCD treatment studies, the methodological quality of the 
treatment literature has not received the same amount of focus in the systematic 
reviews. The previous relevant meta-analyses that investigated the effect of 
psychological treatment for OCD (Abramowitz, 1996, 1998; Abramowitz et al., 2002; 
Olatunji et al., 2013; Rosa-Alcázar et al., 2008) and four meta-analyses that evaluated 
both pharmacological and psychological treatments (Abramowitz, 1997; Eddy et al., 
2004; Kobak et al., 1998; van Balkom et al., 1994) did not include a systematic 
methodological evaluation of the reviewed studies. Specifically, the following 
methodological aspects were not systematically assessed (from Öst, 2008): statistical 
power, reliably diagnosing participants, reliability of primary outcome measures, 
number of therapists, adherence and competence, credibility rating, control of drug 
treatment, assessment of response and remission, independence and blindness of 
raters, and rating of methodological quality (Table 2).  
Of the nine previous meta-analyses reviewed, only four provided some form 




Rosa-Alcázar et al., 2008; van Balkom et al., 1994). Two meta-analyses  (Eddy et al., 
2004; Rosa-Alcázar et al., 2008) evaluated whether or not participants were diagnosed 
according to standardized clinical interview. These two meta-analyses and van Balkom 
et al. (1994) study were alone in assessing control of concomitant drug treatment. 
Olatunji et al. (2013) and van Balkom et al. (1994) assessed adherence to the treatment 
manual. Olatunji et al. (2013) and Eddy et al. (2004) evaluated blindness of raters. 
Three analyses (Olatunji et al., 2013; Rosa-Alcázar et al., 2008; van Balkom et al., 
1994) rated risk of bias; however, two of these only applied the fail-safe N, which is 
not regarded as sensitive enough for the detection of publication bias, as pointed out in 
Paper I. Reliability of the outcome measure was ensured in six of the nine meta-
analyses, although the primary outcome measure varied between the studies.  
All meta-analyses compared the included studies according to the primary 
outcome, as would be expected in a meta-analysis. By standardizing treatment 
outcome in terms of effect size, the treatment effects across studies and measurement 
can be compared. However, to standardize treatment outcome and calculate effect 
sizes represent a methodological issue. Although effect size indices are based on 
standardized mean differences, there are several ways of defining what differences to 
use. There may be differences in the way treatment studies have calculated effect sizes 
due to various research designs, and these differences must be taken into consideration 
when aggregating effect sizes across studies when a meta-analysis is conducted 






























































































Background data + + + + + + + + + 
Treatment data + + + + + + + + + 
 
Review of methodological issues 
         
Statistical power - - - - - - - - - 
Reliably diagnosing patients - + + - - - - - - 
Reliability of primary outcome measure - + + + - + + + - 
Number of therapists in the study - - - - - - - - - 
Adherence and competence ratings + - - - - - - - + 
Credibility ratings - - - - - - - - - 
Control of drug treatment - + + - - - - - + 
Assessment of response and remission - - + - + + - - - 
Independence and blindness of raters + - + - - - - - - 
Rating of methodological quality + + - - + - - - + 
Rating risk of bias + + - - - - - - + 
 
Outcome data 
         
Primary measure + + + + + + + + + 
Response - - + - + + - - - 
Remission - - + - - + - - - 
Within-group effect size + + + - + - - + + 
Comparison of type of CBT + + + + + + + + + 
Note: All items are rated on dichotomous variables (presence or absence). (2) Review of 
methodological issues is based on whether the issue was addressed in the meta-analysis. (3) 
Rating of methodological quality scores was indicated if a specific methodological rating 





calculated as (Mactive treatment − Mcomparison) / SDpooled, based on the difference between the 
treated group and the control group in the post-test (Abramowitz, 1997; Abramowitz et 
al., 2002). The within-group effect size is the difference between the pre- and post-
treatment measurements and can be calculated as (Mpre – Mpost)/SDpre (Abramowitz, 
1996; Eddy et al., 2004; Olatunji et al., 2013; Rosa-Alcázar et al., 2008; van Balkom et 
al., 1994). It is a well-established statistical finding that within-group effect sizes tend 
to be larger than are between-groups effect sizes (Lakens, 2013), thus it is perhaps 
problematic that one meta-analysis calculated effect sizes by combining the pre–post 
change and between-groups comparison (Kobak et al., 1998). In any case, it is 
preferable that meta-analyses provide both between-groups and within-groups effect 
sizes as these different indices of effect size are not directly comparable (Morris & 
DeShon, 2002). Unfortunately, this can be hard to achieve; for instance, Eddy et al. 
(2004) were able to retrieve sufficient data only from three studies for calculation of 
the pooled between-group effect size across the psychological treatments, compared to 
13 studies for the pre–post effect size. Obviously, this is problematic, as similar to in 
this meta-analysis, the pre–post effect sizes were larger than were those from 
comparisons between treatment and control. 
Treatment response was addressed in three of the meta-analyses and only two 
addressed proportion of remitted patients. Treatment response is a central aspect when 
evaluating treatment outcome, however, the way of defining treatment response varies 
between studies, generally in CBT treatment for anxiety disorders (Loerinc et al., 
2015). Although effect sizes demonstrate the statistically significant change after 
treatment, Jacobson and Truax (1991) argued that this is not informative with respect 
to clinically significant change. To assess clinical improvement, they suggested that 
criteria for change should reflect whether a patient had reliable symptom reduction 
(reliable change index; RCI) and is in the non-dysfunctional range after treatment. 
Patients can then be classified as recovered, improved, unchanged and deteriorated 
accordingly. To be recovered, a patient must have a) a symptom change that exceeds 




population after treatment. Fisher and Wells (2005) recommended a cut-off score on 
the Y-BOCS of 14 based on review studies. 
van Balkom et al. (1994), in an early meta-analysis of behavior, cognitive and 
pharmacological therapies, evaluated certain quality variables. For behavior therapy 
studies, the quality variables duration of treatment, therapist contact, treatment 
integrity, and control of concomitant drug treatment were assessed. One of the quality 
variables, duration of treatment, was related to treatment outcome, with longer 
treatment duration being associated with higher effect size. Even so, it may be debated 
if duration of treatment really represents an aspect of methodological quality, as this 
variable could be coded as a treatment characteristic. 
 Kobak et al. (1998) meta-analysis of pharmacological and behavioral treatment 
of OCD examined the relationship between methodological variables and effect sizes. 
Five methodological characteristics of the included studies were coded: effect size 
method (between subjects change scores vs. between subjects endpoint scores vs. 
within-subjects pre–post treatment), control group (presence vs. absence), random 
assignment (random vs. non-random) publication form (refereed journal vs. other 
source), and type of outcome measure (observer rated vs. self-rated vs. pooled). The 
analysis showed that the effect size for ERP was significantly larger compared to with 
serotonin reuptake inhibitors (SRI), but this effect was no longer significant when the 
methodological variables were controlled for, indicating a relationship between 
methodological quality and treatment outcome. These results must be treated with 
caution. As evident from the methodological aspects that were evaluated, this meta-
analysis also included non-randomized studies, studies published in non-peer-reviewed 
journals and pediatric treatment studies. In such heterogeneous samples that include 
non-randomized samples with less methodological stringency, the implications and 
generalizability of the results will be somewhat unclear.   
In a large meta-analysis covering both pharmacological and psychological 




treatments, for example, the application of ITT statistics, reporting of proportions of 
improved and recovered patients, and reporting of comorbidity based on a diagnostic 
screening. The methodological quality was only assessed in a descriptive manner and 
the relationship between methodological aspects and treatment outcome was not 
tested. Based on the review of the methodological aspects and inherent weaknesses of 
the included studies, Eddy et al. (2004) suggested some welcomed advice for 
improved methodological quality in treatment research. Especially relevant for the 
present thesis were the methodological suggestions that resemble items from Öst’s 
(2008) scale, for instance reporting comorbidity, conducting ITT analyses and 
reporting proportions of improved and recovered patients. 
 In Rosa-Alcázar et al. (2008) more recent meta-analysis, the authors also 
investigated if methodological characteristics moderated treatment outcome. The 
methodological characteristics studied were type of design, type of control group, 
control of concomitant treatment, attrition, and the d index in the pretest. These aspects 
were all coded as dichotomous variables. In addition, the overall methodological 
quality was rated on a zero-to-five scale. The application of dichotomous variables and 
the small range of the overall zero-to-five methodological quality scale give a 
restricted range of scores, which makes it difficult to analyze the relationship with 
effect size. The only detected relationship between methodological aspects and 
outcome in Rosa-Alcázar et al. (2008) study was attrition, with the results showing 
that attrition in the control group was related to effect size, i.e. the higher the attrition 
the larger the effect size. When the study with the highest attrition rate (Vogel et al., 
2014) was removed from the analysis, this relationship was no longer statistically 
significant. 
If the comparison between two treatments yields non-significant differences, 
one cannot conclude that the treatments are equally effective. For this conclusion to be 
drawn, a non-inferiority design or an equivalence test is necessary (Walker & 
Nowacki, 2011). A sufficient sample size is required for a superiority design and the 




2001) recommended a cell size of at least 30. Unfortunately, in treatment research on 
OCD, few studies have a large enough sample size and consequently, most studies are 
too underpowered to conduct a test of superiority. This is illustrated in Rosa-Alcázar et 
al. (2008) meta-analysis that included 19 studies with 24 comparisons between 
treatment and control conditions. The mean cell size in the included studies was 18 
subjects, and only four of the studies had conditions with cells equal to or exceeding 
30 subjects, which means that the majority of studies were too underpowered to draw 
conclusions concerning superiority. Nevertheless, such conclusions are often drawn 
anyway, which is a problem that is rarely addressed, both in general treatment studies 
and in meta-analyses. 
 Olatunji et al. (2013) meta-analysis evaluated two methodological aspects on a 
dichotomous scale (presence or absence): if studies applied treatment integrity checks 
and if studies used blind assessors. The moderator analysis showed that these 
methodological characteristics were unrelated to effect sizes.  
 With regard to the unknown methodological quality in OCD treatment research 
and the possible effect on treatment outcome, it is good that three meta-analyses 
explicitly aimed at investigating methodological quality as a moderator of treatment 
results (Kobak et al., 1998; Olatunji et al., 2013; Rosa-Alcázar et al., 2008). However, 
they share some limitations. The most important is that none applied a specified 
measurement scale for evaluating methodological quality. Thus it is difficult to 
compare the rating of methodological aspects provided in each meta-analysis. This is 
partly explained by the fact that there is no widely established rating form for 
methodological quality, and of the scales that do exist (e.g. the criteria proposed by 
Jadad et al., 1996), many are limited to dichotomous scores (presence vs. absence) 
with a small range for total score (e.g a maximum of five points on the Jadad et al., 
1996 scale). This causes difficulties when studying the possible relationship between 




 To overcome these limitations, Öst (2008) developed a rating scale for the 
evaluation of the methodological quality in randomized controlled treatment studies. 
The scale has 22 items assessing various aspects of methodological quality, which are 
rated on a zero-to-two scale (0=poor, 1=fair, and 2=good), with a theoretical total 
range of 0–44. The wide scoring range allows for increased variability and thus may 
be more applicable when evaluating treatment quality and comparing its relationship 
with treatment outcome. Öst (2008) first applied the scale in a systematic review and 
meta-analysis of the efficacy of what has been named the third wave of behavioral 
therapies (Hayes, 2004). The evaluation showed that the methodological quality of the 
third wave studies was inferior to CBT studies.  
 Öst (2014) updated the meta-analysis due to the large number of studies on 
acceptance and commitment therapy (ACT) published since the first meta-analysis. A 
relationship between methodological quality and effect size was found, i.e. the lower 
the methodological quality the higher the effect size. This was an interesting finding, 
suggesting that studies with poorer methodological stringency may actually show 
better treatment effect, which again implies that poorer methodological quality may 
inflate effect sizes. It is obviously of importance to investigate if such a relationship is 
also true for RCTs on the treatment of OCD. As evident from the review of the 
previous meta-analyses described above, the methodological quality in OCD research 
is not well understood and it is not known if methodological aspects influence 
treatment outcome. However, such a relationship is not implausible since 
methodological quality concerns aspects like the degree to which the therapist adhered 
to the manual and with what competence – variables that could be hypothesized to 
have an impact on the treatment outcome. Öst (2014) also investigated if there had 
been progress in methodological quality during the seven-year period after the first 
meta-analysis by evaluating if the research field had implemented the 
recommendations for improved methodological stringency provided in the original 




meta-analysis, with the results showing that the methodological quality had not 
improved during the time succeeding the original meta-analysis.  
A review of the methodological quality of RCTs on the treatment of OCD has 
not previously been conducted to the same extent as for the third wave of behavioral 
therapies (Öst, 2008) and for ACT (Öst, 2014). A limitation of the methodological 
assessment employed in previous meta-analyses on OCD was that a standardized 
assessment scale was not used, which makes it hard to compare the methodological 
quality in OCD research with related disciplines.  
In order to overcome this limitation, the first aim of the present thesis will be to 
apply the Psychotherapy outcome study methodology rating form (Öst, 2008) to assess 
the methodological quality in RCTs for OCD, as well as providing a traditional 
systematic review and meta-analysis of the treatment literature. Potential moderators 
for treatment outcome will also be assessed. 
1.10  Concentrated Exposure Treatment (cET) in a Group Format 
As referred to above there is a vast empirical body supporting CBT as an 
efficacious treatment for OCD. The core element of such treatment is exposure and 
response prevention (ERP) in which patients systematically approach triggers 
associated with anxiety and distress, without performing rituals or other reassurance 
seeking behaviors. Such treatment has successfully been delivered in a number of 
different formats like individual or group treatment and with treatment sessions 
delivered on a weekly basis or concentrated, with comparable amount of treatment 
delivered in a shorter timespan (e.g. Whiteside et al., 2014). In the current thesis the 
feasibility and effectiveness of a novel, concentrated format where therapist assisted 
exposure was delivered during four concentrated days has been explored. For a 




1.11 Assessment of Clinical Effectiveness  
Assessment of clinical effectiveness can be integrated as part of the treatment 
course. In order to assess clinical effectiveness in routine clinics, the implementation 
of systematic assessment of all patient courses is a feasible way of collecting data on 
treatment processes and outcomes. The idea of systematic assessment in the routine 
clinic is not new. More than 20 years ago, Kazdin (1994) made the case for systematic 
evaluation of clinical practice with the primary argument being enhanced healthcare 
for patients and improving the basis for the inferences drawn about treatment change. 
In this paper and in later work, (Kazdin, 2006) outlined recommendations for the 
methodological aspects that would need to be addressed, like assessment of diagnosis, 
feasible study designs, and data evaluation strategies.  
There have been some studies on data from routine practices that are based on 
the implementation of systematic feedback and assessment of consecutive patient 
courses. Westbrook and Kirk (2005) published a study of patients receiving treatment 
in a public healthcare clinic in the UK. In this clinic, which provides CBT treatment, 
routine outcome data were collected over several years, allowing for analysis of a large 
sample of 1276 patients with various psychological disorders, 75 of whom were 
diagnosed with OCD. The study showed that although treatment was less effective 
than what was obtained in efficacy studies, still about half of the sample improved and 
one third recovered. 
Leon, Davis, and Kraemer (2011) recommended that when assessing the 
clinical effectiveness of treatment at a routine clinic, a small scale pilot study should 
be the initial step. A pilot study is a small scale test of the methods and procedures that 
are later to be implemented on a larger scale (Porta, 2008). As pointed out by Leon et 
al. (2011), the purpose of a pilot study is not to test hypotheses or to provide effect 
sizes that are meaningful to interpret; rather, the pilot study can be conducted to test 
feasibility and explore patients’ acceptance of the treatment, the latter being important 
when evaluating novel treatment approaches. This is of obvious importance for 




consequences for attrition. More importantly, low patient satisfaction would represent 
a possible threat to two of the cornerstones of the working alliance, as defined by 
(Bordin, 1979) – shared goals and agreement on the treatment method. 
When the feasibility of the study has been investigated and the patients’ 
acceptance and satisfaction with the treatment has been evaluated, an effectiveness 
study can then be carried out (Leon et al., 2011). There is no agreed upon definition of 
what constitutes an effectiveness study (Gartlehner, Hansen, Nissman, Lohr, & Carey, 
2006), and degree of clinical representativeness has been proposed as one way of 
operationalizing effectiveness studies to be separated from efficacy studies (Shadish, 
Navarro, Matt, & Phillips, 2000; Stewart & Chambless, 2009), with suggested criteria 
being, for example, treatment carried out in a non-university setting by professional 
therapists with a flexible structure (Hans & Hiller, 2013). Hoagwood, Hibbs, Brent, 
and Jensen (1995), in a paper discussing future directions for treatment research in 
child and pediatric mental health, presented a dimensional model where treatment was 
first studied in an open community setting before it was more carefully scrutinized in a 
laboratory or controlled setting. This way, an effectiveness trial was conducted before 
a randomized controlled trial, compared to the more common practice of first carrying 
out an efficacy trial and then testing the treatment in a clinical effectiveness study. The 
authors argued that carrying out research in this order leads to the ecological validity 
of the treatment being investigated first, before technical aspects and processes of the 
treatment are studied in a controlled setting. Hoagwood et al. (1995) described a linear 
model of scientific progress in which findings from efficacy studies were implemented 
in real world healthcare settings and thereafter, the clinical effectiveness can be 
evaluated. However, this issue may be approached from the other way around. If a 
treatment is neither demonstrated effective in an initial pilot study, nor in a succeeding 
effectiveness study, there may be no reason for the conductance of an RCT. 
In order to obtain increased methodological quality in effectiveness studies on 
OCD (and anxiety disorders in general), Hans and Hiller (2013), in a meta-analysis of 




First, they recommended the use of structured diagnostic interviews in order to obtain 
a reliable diagnosis of the patient. Second, they recommended using symptom 
measures with known and established psychometric properties. Third, they outlined 
the importance of reporting attrition in order to avoid biased estimates of effect sizes 
from completer data, as it is well-known that ITT analyses usually have lower effect 
sizes. In order to succeed in implementing these specific recommendations for 
improved quality in effectiveness studies, the authors suggested the implementation of 
systematic assessment and evaluation of patients in routine clinics, applying the 
abovementioned criteria for increased methodological stringency.  
A pilot study is also a good feasibility test before an RCT is carried out. This 
can be conducted in a pilot-randomized study (Feeley et al., 2009), as exemplified by 
Vogel et al. (2014) in the treatment of OCD. The randomized controlled trial is the 
most stringent test of a cause–effect relationship between an intervention and the 
treatment outcome (Green, 2006; Kendall, 2003). However, for studies of clinical 
effectiveness in the routine clinic, this treatment design may not be the most 
informative. Patients waiting to enter treatment could, for example, be randomized to a 
waiting list, but for the treatment of OCD, there is not much to gain from this type of 
control and thus, such a design would be less relevant. Following an effectiveness 
study, a replication study could instead be a viable research option.  
Makel et al. (2012) remarked that replication studies rarely occur in psychology 
research. From reviewing the 100 psychology journals with the highest impact factor, 
they concluded that the replication rate for psychology research was only 1 %. 
Although Makel et al. (2012) included psychology research in general and not clinical 
psychology studies particularly, the findings are also of relevance for research on 
psychological treatment. As commented by Lilienfeld and Pinto (2015), this figure 
may actually be overly optimistic with respect to research on psychopathology, for 
example due to the difficulty of recruiting patients to clinical psychology research. 
Makel et al. (2012) found that more than half of the replication studies were conducted 




APA Division 12 Task Force (Chambless et al., 1998) criteria for categorizing 
empirically supported treatments. In order for a treatment to be considered “well-
established” the treatment must be supported by at least two RCTs by different 
research teams and have showed superiority to placebo or equivalence to a previously 
established treatment. Makel et al. (2012) found that replications were more likely to 
be significant when carried out by the same researchers as the original study, 
underscoring the importance of replication by independent teams. The specific 
requirement that a treatment is replicated by an independent team makes it even less 
understandable that replication studies are so rarely performed. 
The CBT effectiveness studies meta-analytically reviewed by Hans and Hiller 
(2013) had methodological limitations as would be expected in studies with 
nonrandomized designs. Of the included studies specific limitations included risk of 
bias due to lack of control of third variables, lack of reported attrition rates and 
completer analyses instead of intent-to-treat analyses. The authors stress the need for 
more high-quality studies to be conducted due to the inherent methodological 
limitations in the existing body of empirical data. However, the methodological 
limitations from nonrandomized clinical effectiveness studies must be viewed in a 
different framework than should the results of RCT efficacy studies. A central aim of 
an effectiveness study is to establish the clinical effectiveness, and to conclude if the 
treatment is effective, feasible and acceptable when delivered at a routine clinic to 
consecutively referred patients.   
In order to assess clinical effectiveness on relevant primary and secondary 
outcomes in the present thesis, systematic assessment of all patients undergoing 
treatment at the clinic will be implemented. In the following section a brief description 




1.12 Clinical Effectiveness in the OCD Clinic 
In the treatment of OCD main primary outcome measures will be related to 
disorder specific assessment, including interviews and self-report measures. In 
addition to these instruments, several secondary outcome measures may be relevant to 
include when assessing patients undergoing treatment for OCD. 
1.12.1 Depression  
Depression is among the most common comorbid conditions in patients with 
OCD (Crino & Andrews, 1996a). Although it is not established that comorbid 
depression negatively influence treatment outcome for OCD (Knopp, Knowles, Bee, 
Lovell, & Bower, 2013), there is research to suggest that depressive symptoms are 
ameliorated following treatment of OCD (Anholt et al., 2011). Depressive 
symptomatology should be assessed in order to evaluate if these symptoms actually are 
altered following treatment of OCD or if additional treatment interventions targeting 
the depression are necessary. This is relevant as research shows that quality of life in 
OCD patients is more severely affected in patients with high comorbidity, with 
depression accounting for most of the variance (Huppert et al., 2009). Consequently 
structured interviews should be applied before treatment to establish comorbidity, and 
self-report measures should be used to assess severity of depressive symptoms.   
1.12.2 Occupational functioning 
OCD is a debilitating illness with severe impairment of working abilities 
(Bobes et al., 2001). Functional impairment is commonly experienced among patients 
with OCD. Research shows that it is commonly reported that OCD patients are unable 
to work, with lost income as a consequence (Mancebo et al., 2008). Functional 
impairment is recognized in the DSM-IV as one of the key symptoms of OCD, still 
occupational dysfunction has received little attention in empirical research (Markarian 
et al., 2010). In treatment studies, reduction of OCD symptoms receives more focus. 




assesses frequency and distress related to obsessions and compulsions, and the item 
assessing impairment is broadly defined. A systematic review on work related 
treatment outcome identified only four studies on treatment of OCD that focused on 
these aspects (Noordik, van der Klink, Klingen, Nieuwenhuijsen, & van Dijk, 2010), 
which indicates that this topic has received little attention in the treatment literature. 
Given that OCD is known to cause considerable work impairment it is a 
relevant research topic to what extent treatment leads to increased occupational 
functioning, in addition to reduction in OCD symptoms.  To investigate the degree to 
which patients have improved occupational functioning after treatment is a topic that 
should be investigated to a greater extent as a secondary outcome measure. The 
systematic review by Noordik et al. (2010) showed inconclusive results with regard to 
what extent CBT has an effect on work related impairment, which may be due to the 
limited empirical body reviewed with only four OCD studies included. To investigate 
if patients return to work after treatment this must be assessed during the follow-up 
period after treatment. 
1.12.3 Treatment acceptance 
 Treatment acceptance is in the present thesis defined as constituted by three 
main components: Refusal rate, attrition rate, and treatment satisfaction. Firstly, 
refusal rate is understood as if a patient declines the offer of treatment. Franklin and 
Foa (1998) estimated that 25% of OCD patients refuse the offer of treatment due to 
exposure therapy being too frightening to undergo, however, many studies do not 
assess if patients apprehended the treatment principles in order to make a well 
informed decision. . In order for this to be a valid indicator of acceptance it must be 
ensured that the patient is able to make an informed decision, for which the Borkovec 
and Nau (1972) Reaction to treatment scale has been applied (e.g. Vogel et al., 2004). 




Secondly, attrition is an indicator of a patient’s acceptance of treatment as 
patients who drop out cannot be expected to accept the treatment. A drop-out rate of 
25-30% has commonly been reported (Franklin & Foa, 1998),  and higher premature 
dropout rates have been observed in patients with higher symptom severity (Aderka et 
al., 2011). Thirdly, a patient’s self-reported treatment satisfaction is a direct measure 
of treatment acceptance. The participating patients’ degree of satisfaction with the 
treatment process and outcome can be assessed both by self-report questionnaires as 
well as clinician administered interviews.  
1.13 Research Aims  
The main research aims addressed in the present thesis were the following: 
1. To provide an updated state of the art meta-analysis for the treatment of 
OCD, applying traditional meta-analytic approaches combined with an 
evaluation of the methodological quality in the CBT studies for OCD. 
Specific aims were to evaluate potential moderators of treatment outcome, 
evaluate methodological quality, and provide recommendations for 
enhanced methodological stringency (Paper I). 
2. To assess the clinical effectiveness if a novel ERP treatment format, 
Concentrated Exposure Treatment (cET), delivered at a routine clinic for 
OCD. Specific aims were to investigate the following questions (Paper II 
and III): 
a. Will the patients accept the treatment format?  
b. Will the treatment format yield significant changes in primary 
outcomes?  





3. To investigate whether or not the cET treatment format is replicable for a 
new sample of OCD patients. Specific aims were to investigate the 
following questions (Paper IV): 
a. Whether or not the treatment results of a new patient sample in Paper IV 
are comparable to the initial sample in Paper III 
b. Whether treatment results are comparable when treatment is delivered by 




2. Methods and Results 
A presentation of the main methods and results of the four papers included in the 
current thesis will be provided in this section. For a more detailed description, please 
refer to the Methods and Results sections of the individual papers attached. 
2.1 Paper I: “Cognitive behavioral treatments of obsessive-compulsive 
disorder. A systematic review and meta-analysis of studies published 1993–
2014.”2  
2.1.1 Research aims  
 Research aims of Paper I were to provide an updated systematic review and 
meta-analysis of CBT studies for OCD published 1993–2014, and to conduct a 
methodological review of the included studies in order to provide recommendations 
for improved methodological quality in future research. Further, potential treatment 
moderators were investigated. 
2.1.2 Procedures and methods 
 A total 37 studies were included in the meta-analysis following electronic 
searches in the PsychINFO and PubMed databases. The criteria for inclusion in the 
meta-analysis were 1) studies applying the clinician administered Yale-Brown 
Obsessive-Compulsive (Y-BOCS; Goodman et al., 1989), 2) randomized controlled 
trials, and 3) treatment with CBT (CBT, CT or ERP) for OCD. Results on the primary 
outcome measures (Y-BOCS) at the time of pre-treatment, post-treatment and follow-
up were extracted for calculation of effect sizes. All studies were evaluated according 
to Öst (2008) Psychotherapy outcome study methodology rating form. Potential 
moderators were identified and extracted.  
                                              




2.1.3 Statistical analyses 
 Scores on the clinician administered Y-BOCS were used to calculate effect 
sizes. Separate measures for depression and general anxiety were included in separate 
calculations. Effect sizes were calculated as (Mactive treatment − Mcomparison) / SDpooled. The 
effect sizes were calculated separately for post- and follow-up assessments. Potential 
moderators were investigated with subgroup analyses or meta-regression analyses. The 
meta-analysis was conducted using the statistical software Comprehensive Meta-
Analysis version 2.2.057 (CMA; Biostat Inc., 2006). 
2.1.4 Summary of results 
The results from studies comparing CBT to waiting list and placebo conditions, 
the results indicated very large effect sizes favoring CBT (1.31 and 1.33, respectively). 
Comparisons between individual and group treatment (0.17) and comparisons between 
exposure and response prevention vs. cognitive therapy (0.07) were small and non-
significant. The results showed that CBT was significantly more effective than was 
antidepressant medication (0.55), but CBT + medication was not better than CBT + 
placebo (0.25). The meta-analysis revealed a number of methodological problems in 
the included studies and addressed suggestions for improved methodological quality in 
future research, highlighting the need to gain consensus concerning cut-off scores for 
response and remission in the field of OCD treatment research.  
2.2 Common Methodological Aspects of Paper II, III and IV 
2.2.1 Procedure 
All patients were referred to the specialist health care due to severe OCD and 
accepted the offer of treatment. After screening sessions, the patients participated in 
the four-day treatment program described below. Patients were systematically 
evaluated throughout the treatment course at pre-treatment, post-treatment, and at 




2.2.2 The cET format 
The treatment format described in Paper II, III and IV (Concentrated Exposure 
Treatment; cET) is developed by Gerd Kvale (GK) and Bjarne Hansen (BH) and 
combines elements from both individual and group treatment. Prior to initiation of 
treatment groups, the patients meet for screening sessions covering structured clinical 
interviews to assess diagnoses, assessment of symptom severity of OCD, and general 
psychoeducation of the treatment. Each group consists of 3-7 patients and the same 
number of therapists. This ensures adequate therapist resources to sufficiently tailor 
the treatment to each patient. It also provides the individual patient with opportunities 
to observe how the same principles are applied to other patients suffering from OCD 
with different types of obsessions and compulsions. The individual patient does not 
necessarily perform the exposure training with the same therapists all the time during 
the two days of exposure (Day 2 and 3). 
Day 1: Duration: 3 hours. To ensure that all patients are provided with a 
detailed understanding of the treatment principles, on the first treatment day the 
patients meet together for psychoeducation (1.5 h) and detailed planning of  individual 
exposure tasks to be conducted in the days to follow. Instead of constructing exposure 
tasks according to a pre-defined exposure hierarchy, the patients are encouraged to 
suggest exposures that would be expected create the most profound and useful 
changes, and especially to ensure that the exposures cover the most challenging 
obsessions and compulsions. The exposures are not aimed at disconfirmation of 
expectations or at anxiety reduction, but rather on fully approaching all triggers, 
recognize the urge to avoid or neutralize and then approach (“lean in”) rather than 
avoiding or neutralizing (“hold back”). The patients are explained that the core 
element of the treatment is to practice this approach to emotional regulation whenever 
they recognize an opportunity. 
Day 2 and 3: Duration: 8-10 hours. These two days are reserved for exposure 




“leaning into discomfort”. Furthermore, the exposures are not aimed at 
disconfirmation of expectations or at anxiety reduction, but rather on fully approaching 
all triggers without holding back. Typically, exposures are conducted in the most 
relevant contexts (home, workplace, etc.), and if possible, combinations of different 
class of triggers are approached simultaneously.  Loop-tapes with the patient-recorded 
discomforting scenarios to increase the uncertainty in a given situation are frequently 
used. From 9 a.m. to 4 p.m. the group meets briefly in the morning, at lunch and at 
3.30 in the afternoon to share experiences. The remaining time is typically dedicated to 
individual therapist assisted exposure practice.  Typically the 8-10 hours are 
characterized by focused exposures combined with normal small-talk, laughs and 
humor, where the therapists actively ensure that the uncertainty triggered by the 
exposures also is highlighted and processed during periods of small-talk. From 4 p.m. 
to 9 p.m. each patients typically practice on their own, and sends SMSs to the therapist 
when they have completed a given tasks. In these SMSs they are instructed to rate their 
own success of “leaning into the anxiety” on a 1-6 scale where 6 indicates that they are 
not holding back.  When the patients are tempted to start ritualizing or to hold back, 
they are encouraged to rather increase discomfort (“do the opposite of what the OCD 
is demanding”).  At 9 p.m. all patients have a brief communication with the therapist, 
typically only an SMS. If they rate themselves 4 or lower on the “leaning into the 
anxiety” scale, the therapist trouble-shoot for example by having a short talk aimed at 
assisting the patient to stick to the task of leaning fully into the anxiety or discomfort. 
A 2-hour psycho-educative meeting for family and friends is arranged on the afternoon 
on day 3.  During this session the general treatment principles are covered, with a 
specific focus on family accommodation issues.  
Day 4: Duration: 3-4 hours. On the final day of treatment no exposure 
assignments is conducted. Rather, the main focus is to summarize the lessons learnt 
during treatment. The patients also make plans for the following three weeks, with the 
focus being on how to implement the treatment principles in the daily life, to make 




normal life. Relapse prevention is also addressed with specific advice on how to keep 
practicing the principles of ERP in the time following treatment.  
Post-treatment practice: During the three weeks after treatment, patients 
practice the treatment principles on their own in order to implement the changes in 
their natural environment. Patients complete self-report questionnaires to monitor the 
extent to which they adhere to the treatment principles (e.g. if complete response 
prevention is still practiced).  
Follow up: Three months after treatment the patients are invited for a follow-up 
session. As part of the regular assessment of clinical effectiveness the Y-BOCS is 
administered by an independent rater over telephone three and six months after 
treatment.  
2.2.3 Therapists 
Each treatment group was led by an experienced clinical psychologist in the 
team. One of the developers (BH) of the cET format had several years of experience as 
the head of an in-patient clinic for OCD-treatment as well as had extensive training 
and practice in CBT for anxiety disorders exceeding 10 years of experience with OCD 
(Hansen, Vogel, Stiles, & Götestam, 2007). The other developer (GK) had more than 
30 years of clinical experience and more than 10 years of experience with one-session 
treatment of specific phobia (Haukebø et al., 2008; Vika, Skaret, Raadal, Öst, & 
Kvale, 2009) in addition to several years of experience with a 4-day treatment format 
for chronic fatigue (Hansen, Kvale, Stubhaug, & Thayer, 2013). Except from BH and 
GK, the number of therapists in Paper II was six. A total of six groups are included in 
the Paper III sample. In Paper IV there were six therapists, of whom no-one 
participated in the treatment groups reported in Paper III. The developers of cET (GK 
and BH) were in charge of two of the ten groups in Paper IV. In the remaining eight 
groups GK and BH were available on request for consultation but did not participate 
actively otherwise. Please refer to Table 3 for an overview of therapist overlap in 




a psychiatrist who initially started out with very limited experience with treatment of 
OCD. An integrated part of the therapist training consisted of the less experienced 
therapists observing and taking part in treatment sessions led by the experienced 
therapists. Parallel with the treatment described in the present thesis the therapists 
were undergoing a national ERP training program (Kvale & Hansen, 2014). The 
national training program was led by internationally recognized experts of OCD 
treatment and research, including Professor Jonathan Abramowitz (University of North 
Carolina), Associate Professor Martin E. Franklin (University of Pennsylvania) and 
Professor Joseph A. Himle (University of Michigan). The program included days 2 x 3 
days of lectures and workshops, in addition to clinical supervision. 
2.2.4 Outcome assessment 
All patients met diagnostic criteria for OCD according to the administration of 
the Mini International Neuropsychiatric Interview (M.I.N.I;  Sheehan et al., 1998).  
Severity of OCD was assessed using the Y-BOCS, and an independent clinical 
psychologist administered assessments at post- and follow-up. The severity of 
symptoms of depression was assessed using the Beck Depression Inventory (BDI; 
Beck, Steer, & Brown, 1996). In Paper II, a specifically developed interview 
concerning treatment satisfaction was conducted on the final day of cET, in addition 
the patients rated satisfaction with the treatment on a 1-6 Likert scale. Treatment 
satisfaction was assessed using the Client Satisfaction Questionnaire (CSQ-8; Larsen, 
Attkisson, Hargreaves, & Nguyen, 1979) in Paper III and IV.  
2.3 Paper II: “Intensive group treatment of obsessive-compulsive disorder: A 
pilot study” 
2.3.1 Research aims 
The primary aim of Paper II was to assess patients’ acceptability of a new 




investigating changes on primary measures of OCD symptoms and secondary outcome 
measures of depressive symptoms and occupational functioning. 
2.3.2 Therapists 
The therapists in Paper II are equal to those in Paper III. See Table 3 for details.  
2.3.3 Sample 
The sample in Paper II consisted of six OCD patients. 
2.3.4 Statistical analyses 
In accordance with Kazdin (2011) recommendations for single case designs, 
statistical analyses were not conducted. Instead, descriptive statistics were obtained for 
each participant. 
2.3.5 Primary and secondary outcome measures 
 The pre-treatment Y-BOCS mean score for the whole sample was 23.5 points 
(range 19–32). The mean score at post-treatment was 5.7 (range 3–14). Follow-up 
assessment at one month follow-up showed a mean score of 6.5 (range 3–14), at three 
months it showed 5.8 (range 3–9) and at six months, it showed a score of 6.3 (range 0–
14). All patients were classified as recovered at post-treatment and at the follow-up 
assessment.   
 The pre-treatment mean BDI score for the six patients was 15.6 (range 3–29). 
The mean score at post-treatment was 12.8 (range 6–22). The follow-up assessment at 
three months showed a mean score of 11.8 (range 1–22).  
2.3.6 Treatment acceptance 
No patients declined the offer of treatment and there was no attrition. The 




acceptance of the treatment format. No patients would have preferred standard 
treatment to the concentrated treatment format.  
Patients were asked to evaluate the treatment each session day using a six-point 
Likert scale from 1 (not satisfied) to 6 (very satisfied). All scores were 5 or 6, 
indicating a very high degree of patient satisfaction. All patients chose the 
concentrated treatment rather than weekly treatment sessions and all patients stated 
that they would recommend the treatment to a friend suffering from OCD.  
 
2.3.7 Occupational functioning 
At the three-month follow-up, five of the six patients reported having resumed 
working or studying.  
2.4 Paper III: “Concentrated ERP delivered in a group setting: An 
effectiveness study.” 
2.4.1 Research aims 
The primary aim of Paper III was to evaluate the patient acceptability of the 
Concentrated Exposure Treatment (cET) in a large group of treatment seeking OCD 
patients. The paper also aimed at evaluating the immediate and long term treatment 
outcomes in terms of changes on primary and secondary outcome measures.  
2.4.2 Sample 
Thirty-seven patients participated in two initial screening sessions prior to 
treatment. Two patients declined the offer of treatment. Thirty-five patients (69% 




2.4.3 Statistical analyses 
Repeated measures ANOVA for Y-BOCS and BDI were conducted. Cohen’s d 
was used for calculation of effect sizes. All statistical analyses were conducted using 
IBM SPSS Statistics version 22.0. 
2.4.4 Primary outcome  
There was a significant reduction in severity of OCD symptoms at post-
treatment and this result was maintained at the three- and six-month follow-ups. For 
the 74 % of patients who had a history of previous treatment, number of previous 
treatment trials was unrelated to treatment outcome. There was a significant reduction 
in symptoms of depression from pre- to post-treatment, with lasting effects at follow-
up.  
2.4.5 Clinically significant change  
 Applying Jacobson and Truax (1991) criteria for clinical improvement, at post-
treatment, 77% of the sample was classified as recovered, 11% as improved and 11% 
showed no change. At the six-month follow-up, 74% were classified as recovered, 
14% were improved and 11% were unchanged.  
2.4.6 Treatment acceptance  
Two of 37 patients (5.4 %) who were offered treatment declined participation 
due to shame related to the content of obsessions and fear of being recognized by other 
participants in the groups. Both were offered individual treatment. One patient (3 %) 
dropped out of treatment due to lack of motivation for adhering to the principles of 
exposure and response prevention.   
At post-treatment, 31 patients completed the CSQ-8. Sixty-nine percent 




the extent of treatment. All patients stated that they would return to the clinic in the 
incidence of future relapse. Overall, the CSQ-8 results showed a high degree of patient 
satisfaction with the treatment.  
2.4.7 Occupational functioning 
Fifteen of the 18 patients who, at pre-treatment, had reported OCD-related 
impairment at work or studies described a positive change at the 12-month follow-up, 
indicating that 83% of the sample experienced substantial improvement at work or 
studies following treatment.  
2.5 Paper IV: “Concentrated ERP delivered in a group setting: A replication 
study”  
2.5.1 Research aims  
The primary aims of Paper IV were to investigate treatment acceptability and 
treatment outcomes of a new sample of patients undergoing cET, delivered by mainly 
other therapists than the originators of cET (see Table 3). An central aim was to 
compare the results with those obtained in Paper III to investigate if the treatment was 
replicable in a new sample treated by other therapists. 
2.5.2 Sample 
The sample consisted of 42 patients (67% females). 
2.5.3 Procedure 




2.5.4 Outcome assessment different from Paper II and III 
The Work and Social Adjustment Scale (W-SAS; Mundt, Marks, Shear, & 
Greist, 2002) was administered to assess OCD related work and social impairment. 
Due to a change in assessment measure for depressive symptoms at the clinic, BDI 
was not administered to all patients and is therefore not reported. 
2.5.5 Statistical analyses 
Statistical analyses on the Y-BOCS were conducted using a linear mixed-effects 
model. Fixed effects were time (pre- and post-treatment, and six-month follow-up), 
comorbidity and type of previous treatment. The number of additional sessions was 
included as a covariate. The patient was included as a random intercept and a scaled 
identity residual matrix was used. Jacobson and Truax (1991) procedure was used to 
calculate clinically significant change. Categorical variables were analyzed using chi 
square analyses. All statistical analyses were conducted using IBM SPSS Statistics 
version 22.0. 
2.5.6 Primary outcome  
The linear mixed effects model showed reductions in OCD symptoms from pre- 
to post-treatment, which were maintained at the follow-up assessment. Comorbidity, 
previous treatment and number of additional sessions in treatment did not show a 
significant effect. To test for therapist effects, the groups led by the developers of the 
cET (BH and GK) were compared to groups led by other therapists (Table 3), 
revealing non-significant differences. The majority of patients expressed very high 
levels of treatment satisfaction. 
2.5.7 Treatment acceptance 
No patients declined the offer of treatment and there was no dropout. Treatment 




2.4.5.2 Clinically significant change  
At post-treatment, 73.8% of the sample was categorized as recovered, 9.5% as 
improved and 16.7% as unchanged. At the six-month follow-up, 59.5% were 
recovered, 16.7% improved and 23.8% unchanged. 
2.4.5.3 Occupational functioning 
Seventy-three percent of the sample reported a positive change in work 
interference six months after treatment. 
2.4.5.4 Replication study  
Pre-treatment characteristics were compared in Papers III and IV. Significantly 
more patients received concurrent psychotropic treatment in Paper III, while all other 
pre-treatment demographic variables were not statistically different. 
The Y-BOCS primary outcome measure was analyzed using a linear mixed 
model. Time and Time x Group analyses revealed only significant effects for time. 
The proportion of patients obtaining clinically significant changes in the two studies 
was compared, yielding non-significant differences between the samples at post-
treatment and follow-up. Treatment satisfaction was equally high in the two samples 













































































































































































































































































































































































































































































































 The papers in the present thesis highlighted several issues related to the 
treatment of OCD. Paper I provided a review of the methodological quality of all 
RCTs of CBT for OCD published 1993–2014 that used clinician administered Y-
BOCS. CBT was supported as the treatment of choice for OCD and was superior to 
the medication, placebo and waiting list conditions, and the treatment was efficacious 
in many different formats. However, several methodological problems in the 
empirical body of OCD studies were identified. Papers II, III and IV provide an 
example of assessment of clinical effectiveness of a novel treatment format 
(Concentrated Exposure Treatment; cET) delivered at a routine clinic. Based on a 
systematic assessment of all patients undergoing treatment, the cET treatment was 
evaluated in an initial small scale pilot study (Paper II), followed by an effectiveness 
study (Paper III), and the replicability of the treatment was demonstrated in a 
systematic replication series (Paper IV). The results showed that cET was an 
acceptable treatment format with promising effects on primary and secondary 
outcome measures. 
3.1 Research aim 1: Systematic Review and Meta-analysis of CBT for OCD 
3.1.1 Meta-analysis on CBT for OCD 
A central aim of Paper I was to provide an updated systematic review and meta-
analysis of treatment of OCD including all RCTs that used the clinician administered 
Y-BOCS. Prior to the meta-analysis conducted in Paper I, Olatunji et al. (2013) 
conducted the most recent meta-analysis on psychological treatment for OCD and 
studies comparing CBT with WLC or placebo controls were included. The main aim 
of this approach is to investigate whether the active treatment is superior to what is 
considered non-active treatment. As would be expected based on the vast empirical 
body showing that CBT outperforms passive controls, the results from Olatunji et al. 
(2013) clearly favored active treatment conditions. Paper I extends the meta-analyses 




meta-analyses relevant for comparison (averaged to nearest %) were 0% 
(Abramowitz, 1998; van Balkom et al., 1994), 3% (Abramowitz, 1997; Kobak et al., 
1998), 5% (Abramowitz, 1996), 19% (Abramowitz et al., 2002), 22% (Eddy et al., 
2004; Olatunji et al., 2013) and 24% (Rosa-Alcázar et al., 2008), which is a clear 
demonstration of the originality of the systematic review and meta-analysis in Paper 
I. 
 Before Olatunji et al. (2013), Rosa-Alcázar et al. (2008) conducted the most 
comprehensive meta-analysis on psychological treatment of OCD. A literature search 
revealed that more than 20 RCTs had been published since Rosa-Alcázar et al. (2008) 
study, which means that there was a substantial increase in treatment studies not 
previously analyzed in meta-analyses of adults. This is also evident from the included 
studies in Paper I, of which only nine overlapped with the sample in Rosa-Alcázar et 
al. (2008) study. Paper I provided a comprehensive evaluation of the methodological 
quality in all CBT studies for OCD from 1993 until 2014. 
The results in Paper I showed that CBT is superior to waiting list and placebo 
conditions, with very large effect sizes. In comparison with the waiting list, the 
overall effect size was 1.31 in favor of CBT and for placebo, the comparison was 
1.33. The effect sizes for comparisons between individual and group therapy were 
small and non-significant (0.17), with similar results for comparisons between ERP 
and cognitive therapy (0.07). Moreover, CBT is efficacious when delivered in many 
different formats with comparable treatment outcomes, which clearly supports the 
robustness of the treatment principles. The comparisons between CBT and SSRI 
conditions were significantly different and in favor of CBT (0.55). Adding SSRI 
medication did not augment the effect of CBT, and the effect sizes for CBT plus 
medication were small and non-significantly different from the CBT plus placebo 
condition. 
 In light of the findings of Paper I it is interesting to study the clinical 




responded from ten hours of CBT, a course of SSRI could be offered instead of 
additional CBT sessions, due to the argument that these treatments are comparably 
efficacious. A preliminary interpretation of the results from Paper I is that the clinical 
recommendation was not supported by our results, as CBT was superior to SSRI. 
However, this interpretation must be treated cautiously. Only four comparisons of 
CBT and drug were analyzed, as we included only studies with CBT as the main 
active treatment. Thus no studies of head-to-head comparisons of drugs were 
included. However, Y-BOCS change scores in the comparisons of CBT and placebo 
in Paper I were more than three times higher than the difference between SSRIs and 
pill placebo in a meta-analysis of pharmacological treatment of OCD  (Soomro, 
Altman, Rajagopal, & Oakley-Browne, 2008). Thus it may tentatively be concluded 
that CBT is associated with larger changes on the Y-BOCS severity scale than 
achieved by SSRIs. Furthermore, the NICE (2006) guidelines recommend that OCD 
patients with severe functional impairment should be offered a combined treatment of 
CBT (with ERP) and SSRI. Again, these recommendations are not supported by the 
results of Paper I, which showed that the effect of CBT was not augmented by 
concurrent SSRI. Again, these interpretations must be considered tentatively as our 
results were based on only six comparisons of ERP + placebo and ERP + medication.   
In summary, the results from the systematic review and meta-analysis in Paper 
I clearly support CBT as an efficacious treatment of choice for OCD. The results 
showed that CBT was significantly better than were antidepressants in the treatment 
of OCD and the effect of CBT was not augmented by adding antidepressants.  
3.1.2 Assessment of methodological quality in Paper I 
Another aim of Paper I was to provide an evaluation of methodological quality 
in the adult treatment literature on CBT for OCD systematically reviewing all 
included studies on methodological aspects according to the Psychotherapy outcome 
study methodology rating form by Öst (2008). As discussed below, even though 




previously published meta-analyses, the methodological quality has not been 
investigated to the same extent as Paper I in earlier meta-analyses.   
 
 In Paper I, the Psychotherapy outcome study methodology rating form by Öst 
(2008) was applied to rate all included studies, using 22 items on a zero-to-two scale. 
When the 20-year inclusion period was divided in half to compare the methodological 
quality in each decade, there was a demonstrable increase in methodological rating 
scores in favor of the most recent ten year period, which is a promising finding 
indicative of improved methodological quality in the more recent RCTs. This finding 
contrasts Öst’s (2008, 2014) two previous meta-analyses, which applied the same 
rating scale and showed no increase in methodological stringency for ACT over two 
successive decades. Moreover, the results in Paper I revealed no relationship between 
methodological quality and effect sizes, contrary to previous research on ACT (Öst 
(2014). This finding is encouraging as it might indicate that the treatment outcome of 
OCD treatment research is not biased by the methodological quality of the studies. 
Öst (2008) also found that the methodological quality in ACT RCTs were inferior to 
the CBT treatment literature, and in the second meta-analysis (Öst, 2014), it was 
concluded that ACT did not lead to significantly higher effect sizes compared to 
CBT.  
 However, despite the abovementioned promising findings, the methodological 
review in Paper I also revealed several methodological problems in the OCD 
treatment literature. One of the most striking findings was the frequent conclusion of 
equal results in many studies comparing two treatments with non-significant 
differences. Twenty-two of the included RCTs that compared two active treatments 
found non-significant differences, although 50% of these drew conclusions about 
equivalent outcomes. This is potentially problematic because, as discussed in Paper I, 
one cannot conclude with equivalence unless a non-inferiority or an equivalence 
design has been applied (Walker & Nowacki, 2011). Three of the included RCTs did, 
however, have a large enough cell size of 30 or more, as suggested in the APA 




superiority design without doing so. The results show that this is a methodological 
consideration not widely used in treatment studies of OCD, clearly representing an 
area for increased methodological stringency. 
 A related methodological issue concerns the application of a power analysis 
before deciding on the sample size. A very low mean score on the item assessing 
power analysis was demonstrated, and the analysis revealed that many studies were 
clearly underpowered. Although 97% had sufficient power to detect a large effect 
size, none would have detected a small effect size (Kazdin, 2003). This shows that 
the OCD research field has substantial room for improvement regarding power 
analyses, which is very similar to psychotherapy research in general. Kazdin (2003) 
recommendations for increased statistical power should thus be welcomed and 
applied.  
 Another methodological problem identified in Paper I concerns the 
investigation of the potential influence of comorbidity on treatment outcome. Only 21 
(57%) of the included studies reported proportions of Axis I or II comorbidities. As a 
consequence, one must be cautious when estimating the prevalence rate of 
comorbidities on the basis of the available research literature, given the risk of bias 
due to comorbidity being generally underreported in treatment studies. This also has 
consequences when testing the relationship between comorbidity and treatment gains 
in meta-analyses, as there is a risk of undetected relationships influencing treatment 
outcomes in studies that fail to conduct a structured diagnostic interview and report 
the results. The question regarding the relationship between comorbidity and 
treatment gains clearly needs to be addressed in future research, both in individual 
treatment studies, as well as in meta-analyses and systematic reviews. 
3.1.3 Assessment of response 
 The Y-BOCS is the “gold standard” for symptom measurement in OCD (Frost 
et al., 1995). Even still, it is somewhat unexpected to note the large variability in 
method for assessing treatment outcome and the way Y-BOCS is applied to establish 




studies apply percentage reduction, which is not an ideal measurement as this is 
dependent on the baseline score (Farris et al., 2013). Consequently, a severely 
affected patient may have a large reduction in Y-BOCS scores from pre- to post-
treatment, but nevertheless still be in the clinical range without this being detected by 
the statistical analyses (Farris et al., 2013). Lewin et al. (2011) pointed out that a 
patient with a pre-treatment Y-BOCS score of 38 might have a 50% symptom 
reduction to 19 and still have moderate symptom severity. In Paper I, 21 studies 
(57%) included data on treatment response and 20 (54%) reported clinically 
significant change. Of the studies that used Jacobson and Truax (1991) or similar 
criteria, the cut-off score varied from <7 to <16. Considering that many studies use a 
Y-BOCS score of >16 as inclusion criterion (Farris et al., 2013), this score may 
appear too lenient to use as a cut-off.  
 A consensus is clearly warranted with regard to what criteria for clinically 
significant change should be applied. It should thus be welcomed that recent research 
has been conducted in order to provide recommendations for optimal outcome criteria 
(Lewin et al., 2011; Farris et al., 2013) based on Y-BOCS score following treatment. 
It remains to be seen whether these recommendations will be implemented in future 
research.    
 The Y-BOCS is, in itself, not an unproblematic scale. The Y-BOCS is not very 
sensitive to change, and the developers have pointed out that a severely affected 
person may have a small but meaningful reduction in symptoms following treatment 
without the Y-BOCS detecting it score (Storch et al., 2010). For example, a patient 
can have a decrease in time occupied by obsessions from 16 hours to eight hours of 
obsessions, i.e. a 50% reduction, without the change being reflected in the total Y-
BOCS score (Storch et al., 2010). The division of separate items for obsessions and 
compulsions is also problematic. A patient may experience frequent and time 
consuming obsessions after treatment, but refrain from ritualizing in accordance with 
the treatment principles. Due to the remaining obsessional symptoms, this patient 
may earn an increased total Y-BOCS score, even though the individual is no longer 




 To address the inherent limitations of the Y-BOCS, the developers adapted the 
original Y-BOCS to a modified version – the Y-BOCS-II (Storch et al., 2010). 
Several improvements were implemented. For example, item 4 (“Resistance to 
obsessions”) was removed, as this item had the lowest correlation with the Y-BOCS 
total score. The developers also chose to increase the scale range from 0–40 to 0–50 
to make it more sensitive to change, especially for patients in the extreme symptom 
severity end. Unfortunately, this extended total score represents a challenge when 
comparing the scores obtained from the new Y-BOCS-II to the vast literature on the 
Y-BOCS-I. Hence, so far, the Y-BOCS-II does not seem to have reached the point of 
being widely used.   
3.1.4 Treatment moderators 
 Paper I also aimed at assessing moderators of treatment outcome. Of the 
categorical variables, completer analyses yielded larger effect sizes than did ITT 
analyses, passive control conditions (waiting list) gave a higher effect size than did 
active control conditions, individual treatment was better than group treatment and 
studies that assessed therapist competence had a higher effect size than did those that 
did not. In Paper I, the RCTs with both active and passive controls were included. 
The finding that the waiting list condition yielded higher effect sizes may be expected 
from previous research (Cunningham, Kypri, & McCambridge, 2013). This is an 
important reminder for researchers in the treatment of OCD to aim at including active 
control conditions in future RCT studies to minimize the well-known risk of inflated 
effect sizes from comparisons with passive control conditions (Hrobjartsson & 
Gotzsche, 2001; Shadish, 2011). That completer analyses yields higher effect sizes 
has been corroborated in many previous meta-analyses (Hofmann & Smits, 2008; 
Loerinc et al., 2015). This implies that using completer analysis may inflate the 
treatment results, as patients who are retained are more likely to show positive 
treatment effects than do those who drop out. Paper I showed that mainly older 
studies applied completer analyses, whereas newer studies tended towards using ITT 




 Of the continuous moderators investigated, three were significantly related to 
treatment outcome: higher proportion of women, higher mean age and higher 
proportion of patients with antidepressant medication were all related to lower effect 
size. That gender was related to outcome was a surprising finding. Although some 
gender differences in OCD have been found in children, these results typically show a 
higher prevalence in males (Geller, Biederman, Jones, Shapiro, et al., 1998; Hanna, 
1995). Gender was not related to outcome in the meta-analyses by Rosa-Alcázar et al. 
(2008) and Olatunji et al. (2013), nor in the systematic review of predictors of OCD 
treatment outcome by Knopp et al. (2013). That older patients had poorer treatment 
outcome may be due to longer illness duration and perhaps less expectancy of 
treatment. However, illness duration has not systematically been found to predict 
treatment outcome, and treatment expectancy was not analyzed in Paper I due to few 
studies reporting treatment expectancy. Olatunji et al. (2013) also found that older 
age was related to lower effect sizes for child and adult studies combined, but when 
the adult studies were analyzed separately this association was not significant. That 
higher proportion of patients with concurrent antidepressant medication was 
associated with lower effect sizes, may be due to poorer motivation in adhering to the 
CBT treatment principles, but treatment motivation and patients’ adherence to 
treatment was not assessed in a sufficient number of studies to control for this in 
Paper I. Although it would be plausible to suspect that patients with concurrent 
medication had more severe symptoms, the moderator analysis of pre-treatment Y-
BOCS in the placebo-controlled studies showed that higher severity was related to 
better treatment outcome. That CBT is an effective treatment for OCD, irrespective, 
at least to a large extent, of patient characteristics is perhaps also illustrated by the 
recent predictor study on pediatric OCD, which concluded that the only significant 
predictor of treatment outcome was age, with younger children having better 




3.1.5 Rating of methodological quality in Paper I and previous meta-analyses 
The value of the update on the methodological review provided in Paper I can 
be evaluated by comparing the review of the methodological data with the 
methodological reviews that were provided in previous meta-analyses on CBT for 
OCD. All of the methodological aspects in Table 2 were assessed for all included 
studies in Paper I. The degree of overlap of the methodological rating with the 
previous meta-analyses can be detected by comparing the ratings of previous meta-
analyses displayed in Table 2 with Paper I. Background data, treatment data and 
primary outcome measure were covered by 100% of the previous meta-analyses. This 
was expected since these variables are commonly covered in systematic reviews and 
meta-analyses. A comparison of CBT types was also covered by 100% of previous 
meta-analyses, which is also expected given that the relevant meta-analyses reviewed 
the CBT treatment literature for OCD. With respect to the remaining variables in 
Table 2, reliability of the outcome measure and within-group effect size were reported 
in 67% of the meta-analyses, rating of methodological quality was discussed in 44%, 
and control of drug treatment, assessment of response and remission, rating of risk of 
bias and response were addressed in 33%. Reliably diagnosing the participants, 
adherence and competence ratings, independence and blindness of raters and 
remission were addressed in 22%. Statistical power, number of therapists and 
credibility ratings were assessed by 0%.  
Rosa-Alcázar et al. (2008) did conduct an evaluation of methodological issues 
in the included studies, but they did not rate studies according to a specific rating 
form. Instead, methodological aspects were rated according to dichotomous variables 
and a zero-to-five scale was used to rate only overall treatment design. This approach 
to the evaluation of methodological quality did not provide a scale with sufficient 
range to investigate the relationship between methodological quality and effect sizes 
in sufficient detail. Rosa-Alcázar et al. (2008) meta-analysis showed a preliminary 
relationship between effect size and attrition. From more thorough statistical 




vanished when the outlier was removed from the analysis. However, the restricted 
range of the scale applied by Rosa-Alcázar et al. (2008), and the majority of 
methodological aspects being rated on dichotomous variables, are important 
limitations of the methodological review in the meta-analysis.   
3.2 Research aim 2: Systematic Assessment of Clinical Effectiveness of a New ERP 
Format  
3.2.1 Treatment acceptability of cET 
A central aim of Paper II, III was to investigate patients’ acceptance of a novel 
ERP treatment format. In the present thesis treatment acceptance was defined as 
comprising proportion of patients declining treatment participation, proportion of 
patients dropping out prematurely, and patients’ reported treatment satisfaction.  
The results showed high treatment acceptability: In Paper II no patients 
declined participation and no one dropped out. In Paper III, the majority of patients 
(94.6%) accepted the offer of treatment and only two patients (5.4%) declined 
participation. The attrition rate was very low, with only one patient (3%) dropping 
out prematurely.  
The assessment of treatment acceptability was a main area of investigation, 
given the brief period in which treatment was delivered. For the collection of routine 
data, systematic assessment of all patients undergoing treatment at the clinic was 
implemented, which enabled the assessment of measurement of patients’ acceptance 
of the treatment format throughout the whole treatment course. On the final treatment 
day, a survey was used to assess different aspects related to satisfaction and treatment 
acceptance. This was conducted as an interview and covered 13 topics relevant to the 
treatment process, outcome and beliefs about maintenance of treatment gains. 
Perhaps of particular importance is the finding that the patients rated the 
treatment alliance as good even though the treatment was delivered by a group of 




days of exposures.  This result is interesting, since seems to challenges the notion that 
a necessary prerequisite for clinical change is the quality of the therapeutic alliance 
(Martin, Garske, & Davis, 2000), typically defined as trust in the one person who is 
responsible for the treatment in addition to agreement on goals and methods (Bordin, 
1979).  These are relevant findings, as previous research has indicated that therapists 
often have concerns related to the patients’ ability to tolerate high levels of distress 
during exposure therapy (Olatunji, Deacon, & Abramowitz, 2009), and especially 
fear that high levels of anxiety might impair the working alliance (Addis, Wade, & 
Hatgis, 1999). Given the demanding high amount of exposure tasks that the patients 
engaged in together with the group of therapists over two intensive days, the strong 
therapeutic relationship reported by the patients is a promising finding.  
The results from Paper III also showed promising results in terms of patient 
satisfaction. Of the 35 patients in the sample, 100% expressed a high or very high 
degree of satisfaction with the extent of treatment, as assessed using the CSQ-8. All 
patients stated they would return to the clinic if they needed treatment for OCD in the 
future. Also on the remaining items, patients expressed an overall high or very high 
degree of treatment satisfaction. An interesting finding with respect to treatment 
satisfaction is the high number of patients who were satisfied with the extent of 
treatment, which is remarkable for a four-day treatment approach. However, the 
patients underwent several hours of exposure exercises during the cET, allowing for 
exposure to multiple contexts within only four days; the same amount of treatment 
hours would take considerably longer to conduct if the patient were to undergo 
treatment once- or twice weekly, which is the common format in public healthcare. 
3.2.2 Primary outcomes of cET 
In Paper II, there was marked clinical improvement for all patients, with a 
large mean reduction in Y-BOCS-assessed symptom severity. The mean that Y-
BOCS scores were highly reduced from pre-treatment (mean 23.5, range 19–32) to 
post-treatment (5.7, range 0–11). During the follow-up period, these results were 




14). Fisher and Wells (2005) calculated a cut-off point to establish if a patient’s post-
treatment score was within the normal or dysfunctional distribution. They suggested a 
cut-off score of 14 points or below, and it is noteworthy that at all post-treatment and 
follow-up assessments points in Paper II, all of the patients’ Y-BOCS scores were 14 
or lower, indicating good effects for all patients.  
Paper III showed significant improvements on primary outcomes. By applying 
Jacobson and Truax (1991) criteria for clinically significant change, at post-treatment, 
77% of the sample were recovered, 11% were improved and 11% showed no change. 
Due to the application of strict criteria for clinically significant change, two patients 
who were classified as unchanged had post Y-BOCS scores below 14, but did not 
have reliable change (a 10-point Y-BOCS total score reduction). At six-month 
follow-up, 74% were recovered, 14% improved and 11% unchanged. These 
promising results show that the cET was associated with significant changes in OCD 
symptoms, and the results were maintained during the follow-up period. 
In Paper III we investigated if treatment outcome was related to history of 
previous treatment, defined as number of previous treatment trials. These results were 
not significant. Further, in Paper IV we investigated if comorbidity as well as 
treatment history were related to the treatment gains. The results showed no 
significant effect of comorbidity or number of previous treatment trials. Due to the 
small sample size these investigations of treatment predictors these findings must be 
treated cautiously, as the studies are clearly underpowered to detect relationships of 
medium or small magnitude. 
Another caution must be advised with respect to what conclusions are possible 
to draw concerning specific treatment aspects of cET that may influence the treatment 
outcome. The investigation of the potential influence on outcome of variables like 
motivation, treatment expectations and compliance with homework was not the scope 
of the current thesis; however, these aspects would be highly interesting to study in a 
larger sample. 
Also, even though Paper IV represents a replication study, all treatment studies 




inherent methodological weaknesses in uncontrolled studies (Nathan, Stuart, & 
Dolan, 2000), the results concerning the replicability of cET should be regarded with 
some caution until controlled studies, preferably from independent research groups, 
have been conducted. 
  
3.2.3 Secondary outcomes of cET 
Another research aim was related to whether or not the cET led to treatment 
gains on secondary outcome measures. Paper II included an assessment of depressive 
symptoms, and the results showed that there was a reduction in BDI-assessed 
depressive symptomatology from pre-treatment (mean 15.6, range 3–29), to post-
treatment (mean 12.8, range 6–22) and three months after treatment (mean 11.8, 
range 1–22).  
In Paper III, both symptoms of depression and work or study impairment were 
assessed. There was a significant reduction in symptoms of depression that was 
maintained during the follow-up period of six months. In addition, work and study 
impairment was assessed 12 months after treatment, with results showing a marked 
reduction in OCD-related work impairment. Altogether, the cET was associated with 
good treatment outcomes on secondary outcome measures. These results  might 
indicate that the patients actually managed to change some important dysfunctional 
patterns of emotional regulation during the two days of exposure training, and that 
they were able to integrate the change as a part of normal life. Firm conclusions 
related to if and when change in these area actually took place was not the scope of 
the current thesis, and in future studies it would be of interest to track the individual 
changes  during both the four days of treatment as well as the three-week period with 




3.3 Research Aim 3: The replicability of cET 
The final research question was related to the replicability of the cET. Overall, 
the results on primary and secondary outcome measures in Paper IV were not 
statistically different from Paper III, indicating that the results in Paper III were 
replicated. However, it must be emphasized that Paper III and IV were conducted by 
the same research team in an uncontrolled design limits, and due to these 
methodological limitations the results must be interpreted with caution. With this 
precaution in mind, the studies still provide useful and important information with 
respect to the replicability of cET. 
As evident from a recent study investigating the reproducibility of 
psychological research (Open Science Collaboration, 2015), few psychology studies 
are reproducible. Makel et al. (2012) showed that replications of clinical psychology 
studies are not frequently conducted, and from 100 psychology journals they found a 
replication rate of only 1%. In addition, when successfully replicated, the effect sizes 
in replication studies are often lower compared to in the original research. Following 
this, an important aim of Paper IV was to investigate whether or not treatment 
outcomes from successive patient samples treated at the same clinic were 
comparable. In Paper IV, a sample of patients undergoing treatment with cET during 
the period following the inclusion in Paper III were assessed, and the results were 
statistically compared with the results of Paper III to investigate the replicability of 
cET.  
The demographic variables in the two samples were comparable. With the 
exception of the results showing that there were significantly more patients receiving 
concurrent SSRI treatment in the Paper III sample, the remaining demographic 
variables were equal in the two samples.  
The Y-BOCS scores were compared in Papers III and IV to investigate 
differences in the primary outcome. Mean scores from all assessment points were 
statistically analyzed and the results showed that there were no significant differences 




measure than is statistically significant change. In accordance with Jacobson and 
Truax (1991) recommendations for calculating clinically significant change, the 
proportion of recovered, improved and unchanged patients was compared in the 
samples. The results showed that there were no significant differences between the 
samples with respect to proportions with clinically significant change.  
Also, assessment of treatment acceptability and occupational functioning were 
compared. The results concerning treatment satisfaction, as assessed with the CSQ-8, 
showed nonsignificant differences between the samples. Overall, the patients in 
Papers III and IV expressed a very high degree of treatment satisfaction. The attrition 
rate is also promising as the overall rate in Papers III and IV was 1.3%. This figure 
may be contrasted with the attrition rate reported in Paper I, which showed a mean 
attrition rate of 15 % and a median of 11 % in the included studies. The proportion of 
patients having a positive change in the work or employment situations was also 
compared, and the results revealed equal proportions of patients with an improved 
occupational functioning.  
An important aspect concerning replicability of a treatment is the degree to 
which the treatment can be delivered by different therapists with similar outcomes. 
Obviously, the ideal replication would be conducted by a different research group, 
and as such the current replication has clear methodological challenges. Nevertheless, 
the results of the present thesis provide some preliminary support for the replicability 
of the treatment format when delivered by different therapists. In Paper III, all 
treatment groups were led by the developers of the cET, whereas in Paper IV, only 
two groups were led by the developers and the remaining groups had other lead 
therapists. Also, the overlap between the therapists in Paper III and IV is limited. The 
replication study showed that the treatment outcome in groups led by the developers 
and the remaining groups did not differ significantly, thus implying that the cET is 




The patient samples reported in Papers III and IV were highly representative of 
OCD patients, as characterized by high levels of symptom severity and a long 
duration of the disorder. In Paper III, the mean duration was 16.7 years, with a SD of 
more than ten years. In Paper IV, the mean duration was 14.5 years, with a similar SD 
as in Paper III. In addition, the majority (74%) of patients in both studies reported 
previous treatment. The rate of comorbidity was also high in the samples. Based on 
the symptom severity and history of previously unsuccessful treatment trials, many of 
the patients would be candidates for inpatient treatment, as suggested in the NICE 
(2006) clinical guidelines. With this in mind, it is promising that the results in Papers 
III and IV showed a high number of recovered patients, in addition to the results 
showing no relationship between outcome and comorbidity or treatment history. 
There seemed to be a positive effect on symptoms of depression for patients 
undergoing treatment, with both Papers II and III showing reduced levels of 
depression symptom severity after treatment. However, due to a change in use of 
outcome measure for depression during the period in which the patients reported in 
Paper IV underwent treatment, the effect on depression was not possible to replicate 
in Paper IV.  
Although the replicability of the cET appears promising as indicated by the 
nonsignificant differences between Paper III and IV, as mentioned, some caution 
when interpreting the results must be noted. Makel et al. (2012) found that 
statistically significant replications were more likely when the replication was 
conducted by the same research team as the original study, as indicated by the results 
showing that of the successful replications more than half were conducted by the 
same research group as the original study. The most important limitation concerning 
the replicability of cET is thus that the replication study in Paper IV was conducted 
by the same research group as in Paper III.  
For a treatment to be empirically supported as a well-established treatment, the 
APA Division 12 Task Force on Promotion and Dissemination of Psychological 




been empirically supported by two independent research teams preferably in 
randomized controlled trials demonstrating the efficacy of the treatment. If all the 
research is carried out by the same research group the treatment would be considered 
possibly efficacious according to the APA task force. To further investigate the 
replicability of cET, future studies should be conducted by independent research 
teams. In order to meet the APA criteria, treatment studies should include 
randomization to a control group.   
In summary, Paper IV offers a demonstration a replication study of a novel 
treatment format delivered in a routine clinic, based on the systematic assessment of 
patient change. Although the replication of Paper III was not conducted by an 
independent group, it provided promising preliminary results which should be further 
investigated in future research.  
3.4 The cET format and Severe and Treatment Refractory OCD Patients  
 The NICE (2006) clinical guidelines recommend inpatient treatment as an 
alternative for patients with severe and/or treatment refractory OCD. A potential 
challenge regarding this clinical recommendation is that there is no clear consensus 
concerning what defines a treatment resistant patient. To be treatment resistant can 
e.g. be operationalized as patients who have undergone one or several treatment 
courses of recommended treatment for OCD (CBT with ERP) without clinically 
significant change. Another definition could be patients who repeatedly relapse after 
initial successful treatment courses.    
 Also, it is unclear if number of previous therapy trials is informative in terming 
patients as treatment refractory. If previous treatment is a moderator of treatment 
outcome was not investigated in Paper I as only 13 (35%) of the included studies 
provided information about this. In addition, there was considerable variation in the 
number of patients having received previous treatment, ranging from 0–100% with 




cET presented in this thesis were characterized by having severe symptoms before 
treatment and most patients – 74 % in both Paper III and IV – had unsuccessfully 
tried previous treatment, including CBT and exposure therapy. The high numbers of 
improved and recovered patients in Paper III and IV, as well as analyses showing that 
previous treatment attempts were unrelated to treatment outcome in both studies, are 
thus promising findings. Relevant research questions that should be addressed in 
future studies therefore concern 1) whether or not there are some patients who are 
resistant to treatment, and 2) if yes, what characterizes these patients, for example, 
the number of previous treatment trials, symptom severity, duration of illness, 
comorbidity and treatment motivation. 
 In their systematic review of predictor studies of OCD, Knopp et al. (2013) 
found six studies that investigated treatment history as a potential predictor of 
treatment outcome and none showed a significant relationship with treatment 
outcome. However, Knopp et al. (2013) concluded that there were substantial 
limitations to the quality of the assessment of predictors in the studies analyzed, thus 
there are still many unanswered questions with respect to predictors of treatment 
outcome. The urge for improved methodological stringency is thus shared by Paper I 
and Knopp et al. (2013) in pointing out that methodological weaknesses limit the 
opportunity for conclusions to be drawn about what predicts treatment response.  
 As evident from the moderator analyses provided in Paper I, high symptom 
severity was not found to impair treatment outcome; to the contrary, high levels of 
pre-treatment OCD symptoms was associated with better treatment outcome.  In a 
study of inpatient treatment for severely affected OCD patients, Brennan et al. (2014) 
found that higher baseline OCD severity predicted a greater percentage of symptom 




3.4.1  cET Compared to Intensive Treatment Formats 
 The term “intensive” has been applied to various treatment formats for OCD. 
Originally, the term “intensive” referred to treatments with daily sessions over three 
weeks to distinguish it from treatment formats with spaced treatment sessions (e.g. 
twice-weekly sessions; Abramowitz et al., 2003). In this case “intensive” refers to the 
duration in time that treatment is delivered. This could be contrasted to the intensity 
of treatment as referring to how much distress or discomfort is experienced by the 
patient during treatment. An example of the latter could be whether the patient 
underwent gradual exposure starting with the least anxiety provoking tasks, as 
opposed to flooding; or if partial or complete response prevention was implemented. 
The problematic issue of how to define intensive treatment was illustrated in Jónsson, 
Kristensen, and Arendt (2015) recent meta-analysis, which reviewed intensive CBT 
for OCD. One of the inclusion criteria was that treatment duration should not exceed 
four weeks. Of the included studies, the reported duration was one to four weeks, the 
session length varied from 50 min to four hours, and the total number of treatment 
hours varied from 10 to 30. Evidently, there was a marked variation in the included 
studies with regard to what was “intensive”. 
The cET treatment format deviated from the intensive treatment formats 
described previously, for example, treatment formats with daily sessions for three 
consecutive weeks (Abramowitz et al., 2003). Although the cET treatment format 
may be described as “intensive” due to the many hours of treatment over two days of 
exposure, for the present thesis it was useful to differentiate between intensive 
treatment and concentrated treatment. Concentrated treatment is characterized by 
treatment delivered over a short duration in terms of number of days and the total 
duration of time under exposure is high. Thus, the number of therapy hours in cET is 
comparable to the 16-hour individual treatment manual from Kozak and Foa (1997). 
cET has more in common with other concentrated ERP formats. Shikatani et al. (in 
press) described a nine-day format with exposure sessions lasting two to four hours. 




the home environment very rapidly and implement the treatment strategies in the 
daily life. By differentiating cET from what has typically been termed intensive OCD 
treatment, it may be argued that cET shares more similarities with the brief treatments 
developed for other anxiety disorders, for instance social phobia (Wells & 
Papageorgiou, 2001), post-traumatic stress disorder (Ehlers et al., 2014), specific 
phobia (Davis III, Ollendick, & Öst, 2012), and panic disorder (Craske, Maidenberg, 
& Bystritsky, 1995), than what has traditionally been termed intensive in the OCD 
treatment literature.  
 There are some notable differences between cET and the team approach 
described in the Shikatani et al. (in press) case study. cET is delivered over four days 
with only two consecutive days of exposure. This allows for exposure to multiple 
contexts during several continuous hours. The high therapist–patient ratio and the 
continuity of therapist contact may help the patient “stay on track” with the exposure 
assignments, allowing for the therapist to spot potential barriers during treatment and 
address them immediately. This can be compared to, for example, a once-weekly 
treatment format, in which the patient is vulnerable with few opportunities for 
therapist contact outside of therapy sessions.  
 The cET format may make delivering treatment particularly feasible due to 
several important factors. Compared to treatment with daily sessions of short 
duration, the four-day format with many treatment hours delivered over two days of 
exposure, may be less susceptible to variation due to patient factors. The patient is 
prevented from drifting from the treatment principles because the initial parts of 
treatment are concerned with the patient learning how to practice the exposure 
assignments and adhere to the response prevention in a limited number of 
assignments, closely supervised by the therapist, before the patient starts to practice a 
number of exposure tasks in multiple situations and contexts. However, these specific 




3.5  Assessment of Clinical Effectiveness  
3.5.1 Clinical effectiveness 
Many years ago, Kazdin (1994) argued in favor of implementing systematic 
assessment of patients undergoing treatment in mental healthcare settings. 
Unfortunately, this has yet to become an integrated part of public healthcare, although 
Kazdin (2006) repeatedly has proposed specific recommendations for how to 
implement such systematic patient assessments. This thesis provides an example of 
how this can be achieved.  
Kazdin (2006) pointed out that there are different study designs that are 
informative when conducting assessments and research on effectiveness in clinical 
practice. Assessment of individual patients in a case series is an example, as provided 
in Paper II. This pilot study with six patients undergoing treatment showed that the 
treatment approach was highly acceptable, thus opening for larger scale studies. 
Paper III extends the pilot study with a larger open effectiveness study of 35 patients, 
which is replicated in Paper IV.   
Although the RCT is often recognized as the ultimate research design for 
psychotherapy treatment studies (Kendall, 2003), this may not be the most ideal 
format when evaluating treatment outcomes at a routine clinic setting. Goldfried and 
Wolfe (1998) argued that controlled trials are of limited value if they lack clinical 
validity and recommended certain measures to be undertaken in order to increase a 
study’s ecological validity. As noted by Lambert (2001), the ecological validity of a 
treatment is much more informed by studies taking place in naturalistic settings, 
where patients normally receive health care. Effectiveness studies can be argued to be 
a more suitable approach to establishing the ecological validity of a treatment. RCTs 
are often conducted in strictly controlled settings that may not necessarily be 
transferable to the ordinary clinical setting. Studies that are conducted within routine 
clinics are more informative in this regard. An alternative research option is therefore 




clinic is replicable over time. Based on the effectiveness research on cET in Paper II, 
III and IV it may be argued that the cET approach has high ecological validity. The 
treatment was conducted on patient sample without exclusion criteria and the patients 
were highly representable for the disorder as evident from high symptom severity, 
long duration of illness duration, a high degree of comorbidity and a substantial 
history of previous unsuccessful therapy trials.  
It has been argued that many patients are offered sub-optimally delivered CBT 
(Shafran et al., 2009), which may be partly explained by the therapist’s lack of 
training. In Papers II, III and IV, all therapists were part of a clinic where they as part 
of their training were working side-by-side with experienced therapists in order to 
observe the treatment interventions. This type of hands on training also allows for 
direct feedback from the experienced therapist to the novice. The cET format may be 
argued to be very transparent with respect to protocol adherence and by the frequent 
meetings where the patients shared their treatment experiences. Thus, cET may be a 
format that allows for close adherence to the treatment manual. As Shafran et al. 
(2009) pointed out, it is a threat to empirically supported treatments when they are 
delivered without adherence to the manual, leaving the patient with suboptimal 
therapy based on a treatment that works. As Waller (2009) pointed out, therapist drift 
is a common process involving a shift from “doing therapies” to “talking therapies” 
(p. 119), which means that less time is spent on behavior change and increased time 
is spent on talking. This is illustrated in Hansen et al. (2007) study, which showed 
that patients who underwent ERP and cognitive therapy had less time for exposure 
due to the cognitive interventions that opened up time for talking, leaving less time 
for exposure work, with results indicating a somewhat reduced treatment outcome.  
  
3.5.2 cET in relation to effectiveness research on OCD 
In a recent review, Öst (2013) summarized the literature on effectiveness and 




studies can be disseminated to the routine clinic. Öst (2013) identified 59 RCTs on 
CBT for OCD and rated the clinical representativeness of the identified studies 
according to four of ten items on Shadish et al.’s (2000) rating scale. By comparing 
the effect sizes obtained in effectiveness studies with the mean effect size from 
efficacy studies of OCD, out of 21 studies, Öst (2013) found that 12 effectiveness 
studies had poorer effect, six had equal results and three had better results compared 
to the mean in the efficacy studies. The average effect size was 2.25 in efficacy 
studies and 1.89 in effectiveness studies, which was not significantly different.  
To compare the treatment effect of cET with the effectiveness studies analyzed 
by Öst (2013), the effect size from the combined samples in Papers III and IV can be 
applied, as the replication study in Paper IV yielded nonsignificant differences 
between the samples. The within-group effect sizes Öst (2013) reported were 
calculated using the formula ES = (Mpre - Mpost)/SDpre). The average Y-BOCS score 
for the samples in Papers III and IV at pre-treatment was 25.9 (SD 4.31), at post-
treatment was 9.97 (SD 4.36) and at six-month follow-up was 11.32 (SD 6.13). By 
using the same formula as Öst (2013), this yields a post-treatment effect size of 3.7 
and a follow-up effect size of 3.38. For within-group effect sizes, 0.5 is considered 
small, 0.8 is medium and 1.1 is large (Öst, 2013). The effect sizes obtained from the 
combined treatment outcome from Papers III and IV can thus be regarded as very 
large. By comparing this result with the outcome for effectiveness studies reported in 
Öst (2013) work, the treatment outcome from cET can be considered promising. The 
effect sizes obtained in cET must be treated with caution, due to the abovementioned 
well-known statistical finding that within-group effect sizes tend to be larger 
compared to between-group effect-sizes (Lakens, 2013). 
3.6 Methodological Quality in the Present Thesis 
 In order to investigate the methodological quality of the effectiveness data 




in Öst (2008) Psychotherapy outcome study methodology rating form. This scale was 
originally developed to rate the methodological quality in RCT studies, which is 
reflected in some of the items. Item 9 (assignment to treatment) is related to the 
procedure for assigning participants to treatment conditions (e.g. whether or not 
patients were randomly assigned), item 10 (design) assesses the type of design (e.g. 
whether or not the active treatment group was compared to another active treatment) 
and item 22 (equality of therapy hours) rates whether or not the amount of therapy 
differed between conditions (for non-WLC designs). Understandably, items 9, 10 and 
22 will not be applicable to a treatment study with only one treatment condition, and 
a score of 0 points must be given. However, it is still possible to rate an uncontrolled 
study on the remaining 19 items. When rating Paper II, the paper obtained 22 points, 
which was equal to 50% of the maximum 44 points. Papers III and IV both scored 25 
points, which was equal to 57% of the maximum points. The mean score of Papers II, 
III and IV was 24 (SD 1.73), which was equal to 55% of the maximum score. The 
mean score of the 37 studies analyzed in Paper I was 23 (SD 4.73), which was 52% 
of the possible maximum scoring range. The difference between Paper I and the mean 
score of Papers II, III and IV was not statistically significant, t(38) = 0.35, p = .73. 
This illustrates that sound methodological quality may also be achieved when 
systematically evaluating treatment outcome in an effectiveness study and replication 
study, rather than with a RCT.  
In summary, through systematic evaluation and by analyzing results in 
effectiveness trials and replication series, one may also achieve good methodological 
quality and representative results in the ordinary clinic setting. With these 
considerations in mind, it seems even less understandable that systematic assessment 
in public healthcare is so rarely performed. 
3.7 Implications for Future Research 
The present thesis offers two main implications for future research. The 




recommended that the field of OCD research take specific actions in order to enhance 
the methodological stringency. It is suggested that the methodological quality in OCD 
treatment research is reanalyzed in ten years according to Öst (2008) scale to evaluate 
if there has been increased methodological quality following the recommendations 
put forward in this thesis. 
Paper I provides some direction for future RCT studies on the treatment of 
OCD in order to improve methodological quality in the research field. Most 
importantly, Paper I addresses several methodological aspects that should be 
improved in future research. The results in the meta-analysis indicate that in RCT 
designs patients should not be randomized to WLC or placebo conditions, as there is 
no reason to expect treatment gains from such passive controls. Instead, active 
treatments should be compared. However, as pointed out, a power analysis must be 
conducted initially and the sample size adjusted accordingly, with a large enough 
sample to allow for superiority designs in order to test for differences between 
treatments. A promising trend was detected, with studies in the later ten-year 
inclusion period having a higher mean methodological rating compared to the studies 
in the first period, indicating an increased methodological stringency over time in 
OCD treatment research. It is hoped that this trend continues, perhaps aided by 
adhering to the recommendations above. 
The second area of research implications regards effectiveness research. Even 
though this has not been a research question in the current thesis, systematic 
assessment of treatment variables at a public healthcare clinic has been a prerequisite 
for data collection. The collected data and treatment results hold high ecological 
quality. It may be argued that the integration of effectiveness research as part of 
ordinary clinical care is important for two reasons. First, whether or not the 
empirically supported treatments for OCD are disseminated in routine clinics needs to 
be established. As Shafran et al. (2009) discussed, there is still a long way to go 
before patients who could benefit from OCD are offered this as the first line 




have the clinical gains that would be expected based on the available research needs 
to be established. Future research on clinical effectiveness from routine clinics should 
be conducted to improve dissemination and establish means for improving the 
adequacy of the treatment delivered.  
In order to establish the evidence base for the cET treatment format, future 
larger scale research and controlled studies by independent research groups are 
needed. Nevertheless, it may be argued that the present thesis provides useful 
preliminary information of the effectiveness of cET. In particular this is due to the 
studies not having been conducted in the traditional top down linear scientific 
progress. This top down approach is typically initiated with an efficacy study, 
thereafter the treatment is disseminated to the routine clinic and the treatment is 
investigated in an effectiveness study. In contrast to this top down approach, the 
thesis proposes a bottom up strategy in which a treatment approach is initially 
described in small scale study. Only when the treatment is accepted and demonstrates 
feasible efficacy are additional studies warranted. In line with this argument, a 
suggestion is made for further research using larger scale controlled trials in which 
patients are randomized to cET and an active control condition.  
Following the treatment processes and outcomes reported in Papers II, III IV, 
there are several suggestions for future effectiveness studies in routine clinical 
settings. The findings that show comparable results using different treatment formats 
may have implications for future research. Given that CBT/ERP is effective for OCD 
irrespective of the presentation method should encourage researchers to investigate 
novel ways of providing treatment, given that a substantial number of patients who 
receive treatment either do not improve or experience a setback or relapse.  
A final area for future research concerns the replicability of the cET approach. 
Although the treatment format was well accepted by the patients and led to promising 
treatment gains, the format should be investigated by an independent research team in 




3.8 Implications for Clinical Practice  
For the treatment of OCD, the present thesis offers some important 
implications for clinical practice. CBT was shown to yield better treatment outcomes 
compared to the use of antidepressant medication, and adding antidepressant 
medication to CBT did not augment treatment effects. A suggested implication for 
clinical practice is that CBT should be the first line of treatment and one may not 
expect medication to enhance the treatment effect. However, as the main aim of 
Paper I was to investigate studies with CBT as the primary treatment, this clinical 
implication must be considered tentative.  
The results from the meta-analysis showed that ERP and CT yielded similar 
treatment effects. This finding has clinical implications and suggests that there is no 
need to combine ERP with CT, given that each alone is supported as an effective 
treatment. However, although CBT can be delivered in different formats, the 
treatment delivered should always be rooted in a treatment manual in order to ensure 
that the documented effective treatment components are in fact included in the 
treatment. Furthermore, no significant differences were found between group and 
individual treatment. These results imply that both formats are efficacious for OCD, 
indicating that the mode of treatment application matters less when treatment patients 
with CBT. 
Some suggestions for clinical practice may also be offered based on the 
evaluation of the cET. By delivering treatment in the format of individualized 
treatment in a group format one may achieve advantages from both individual 
treatment and group treatment. The 1:1 patient-therapist ratio ensures a high degree 
of therapist assisted exposure, which is known to be important for clinical change. 
Also, the group format may enhance treatment motivation in patients by allowing for 
mutual support between the patients.  
As demonstrated in Papers II, III and IV, cET represents a novel treatment 




patient with OCD, rapid symptom reduction following four days of treatment means 
rapid reduction of impairment, which is demonstrated in Papers III and IV, showing 
that patients experienced better work-related functioning. Thus, the social and 
economical benefits are clear, as the concentrated treatment allows the patient to 
return to work at a much faster pace compared to treatments with a lower interval 
between sessions.  
The concentrated format may also have implications for the dissemination of 
treatment. For a patient living at a long distance from the clinic, traveling to the 
psychiatric unit once a week may be very time consuming. Undergoing treatment in 
only four days will the patient to come to the center during the treatment days, and 
thus have a low total number of days traveling. 
3.9 Conclusions  
3.9.1 Research aim 1 
Paper I provides a systematic review and meta-analysis of CBT for OCD. The 
low degree of overlap of reviewed studies compared to previous meta-analyses that 
are relevant for comparison, Paper I may be argued to represent a substantial update 
on the empirical support for CBT in the treatment of OCD. The methodological 
review provided in Paper I exceeds the assessment of methodological aspects that 
have been conducted previously and recommendations for how to increase 
methodological quality in future research is provided.  
3.9.2 Research aim 2 
The second research aim was related to acceptance of cET, as well as treatment 
outcome on primary and secondary measures. Overall the treatment format had high 
acceptability, as indicated by low attrition rates, a low number of patients declining 




and III. Further, the patients had large treatment gains in terms of reduction of OCD 
symptoms, depressive symptoms, and improved occupational functioning.  
3.9.3 Research aim 3 
The third research aim was related to the replicability of cET. Paper IV showed 
that a new patient sample, treated with mainly other therapists than the originators of 
cET, had high treatment gains on primary and secondary outcome measures. 
Treatment acceptability was also high evident from no patients declining the offer of 
treatment, no attrition and high treatment satisfaction. There were no statistically 
significant differences between Paper IV and Paper III, indicating that the cET is a 
replicable treatment format. However, it is recommended that the treatment format is 
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